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GENERAL INTRODUCTION 
The incentive to start this study in 1986 were two patients with lissencephaly, observed during 
my training as a neurologist. Such an exceptional occasion prompted an attempt to collect a 
large group of patients with lissencephaly type I, a rare congenital disorder, in order to increase 
our knowledge about epidemiology, clinical signs, neurophysiological and neuro-imaging 
characteristics, and genetic aspects. Thanks to the cooperation of many colleagues in 
departments of childneurology in the Netherlands, it became possible to collect the patients 
described in this thesis. 
In Chapter 1 a survey of the present knowledge concerning lissencephaly is given. The 
differences between lissencephaly type I and type II are explained. This thesis concerns the type 
I only. Chapter 2 deals about the epidemiology of lissencephaly and is probably the first study 
about the prevalence at birth and the survival rate of lissencephaly type I. The clinical details 
of the patients studied are presented in Chapter 3. 
The diagnostic methods in lissencephaly type I are explored in Chapter 4 (neurophysiology) and 
in Chapter 5 (neuroimaging). A special type of lissencephaly type I, the Miller-Dieker 
syndrome, has recently become related to a deletion of the short arm of chromosome 17. In 
Chapter 6 the details of cytogenetical and DNA-studies are described. Chapter 7 reports three 
patients with the Smith-Magenis syndrome, which is also characterized by a deletion of a part 
of the short arm of chromosome 17. 
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Chapter 1 
A SURVEY OF LISSENCEPHALY 
DEFINITIONS 
The word 'lissencephaly' is a description derived from normal embryologic development, where 
'lissos' means smooth and 'encephalon' means brain. In small lower animals the lissencephalic, 
smooth brain without sulci, is the normal state.[89] Gyrencephaly, the presence of sulci, is 
characteristic for larger animals, including humans. It is peculiar to name a serious 
developmental disorder of the human brain after the normal state of lower animals. Some 
authors use the term lissencephaly for both agyria (meaning no gyri), pachygyria (meaning few 
gyri) as well as for polymicrogyria (meaning very small gyri). Agyria and pachygyria differ in 
degree only. Polymicrogyria, in which an increased number of small sulci is present, has to be 
distinguished from them, but combinations occur, as was reported in one of the first patients 
described [74] and in later reports.[91] 
DEVELOPMENT OF THE BRAIN 
Normal ontogenesis of the nervous system is a complex process that can be divided in phases: 
neurulation; cellular proliferation and neuronal migration; maturation of cellular components, 
synaptic development and myelination. Neurulation refers to the formation of the neural tube, 
which takes place in the third and fourth week of gestation.[122] 
Neuronal migration is occuring in different manners in different pathways: to the neocortex; to 
the cerebellum; to the corpus pontobulbare to form pontine and medullary nuclei; and to the 
corpus gangliothalamicum to form the thalamus and and basal ganglia.[105] Migration of 
neocortical neurons proceeds from the germinal matrix in the ventricular zone, where 
proliferation takes place, to the cortical plate. This proces begins at the 8th week and is for the 
greatest part completed after 16 weeks. According to autoradiographic studies this occurs in 
several waves (stage I to V) in an inside-out fashion; neurons that migrate later, migrate 
through neurons that have migrated earlier. The migration of neurons is guided by their 
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movement along glia fibres, which extend from the ventricular matrix to the cortical plate.[95] 
Neocortical migration can also be classified into radial-proceeding from the ventricular to the 
pial surface and tangential-proceeding parallel to the surface of the brain.[96] According to a 
model the migrating cell can move by adding new membrane components.[96] Most 
investigators agree that glial and neuronal cell surfaces contain binding molecules. These 
molecules promt cell-to-cell binding; lack or alteration of these molecules may result in 
neuronal migration disorders. According to the radial unit hypothesis neurons originating from 
a given part of the proliferative zone form a specific cytoarchitectonic area. Probably, final 
organisation is reached by a combination of intrinsic genetic properties of the neurons and 
axonal input from the subcortical structures during migration. The findings of light and electron 
microscopy with Golgi impregnation in the human fetus suggests an early maturation of layer 
I in cortical genesis.[16] The early establishment of a pial-glial barrier and the early maturation 
of Cajal-Retzius cells within the marginal zone appear to be of importance in the development 
of the neocortex.[16] During the 6th week the cerebellar tubercle begins to grow at the rostral 
end of the 4th ventricle. During the 7th and 8th week the lateral limbs become paired masses 
on both sides of the brainstem and the lateral rhombic lips thicken rapidly. At 8 weeks cells 
begin to migrate along several pathways. One is directed dorsally to form the external granular 
layer of the cerebellum. The others follow a ventral pathway to form the pons (with the inferior 
olives and the pontine nuclei) and the medulla oblongata.[105] 
Little is known about the intra-uterine factors,. responsible for the convoluted form of the 
human brain. Cerebral sulci become visible at the end of the fourth fetal month and continue 
their development until birth.[15,18] The first sulci to appear are the primary and secondary 
sulci. They are relatively constant in location and configuration. The tertiary sulci begin to 
develop in the third trimester, appearing in a more random fashion. 
From experimental studies we know that convolutional development is dependent on events in 
the cortex itself. The developing cerebral cortex of sheep was surgically isolated in utero at a 
time before the appearance of cerebral convolutions, but after the completion of cellular 
migration. At term all animals had cerebral sulci of normal size and configuration.[5] 
Various degrees of abnormal growth of the inner and outer cortical layers may be responsible 
for gyral malformations. In a study based on mathematic and mechanical hypotheses, the 
predicted minimum intersulcal distance ( = gyral thickness) is eight times the cortical thickness 
in normal brain, and equal to the cortical thickness in polymicrogyria. In lissencephaly the 
relative growth of the cortex is assumed to be smaller than normal, and the relative growth 
from the centre of the brain to be greater than normal The forces in the cortex are then not 
sufficient to exceed the critical value necessary to form sulci, resulting in a smooth brain.[99] 
PATHOLOGY OF NEURONAL MIGRATION 
Neuronal migration disorders can be classified as follows: lissencephaly, microgyria, verrucous 
dysplasia of the neocortex, heterotopia, and others.[7] 
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In 1975 an extensive architectonic and topographical analysis of a lissencephalic brain was 
given.[110] Macroscopically a smooth brain surface is seen; sometimes a few broad gyri are 
present. Opercularisation is absent, resulting in an absence of the Sylvian fissure. The claustrum 
and capsula extrema are absent. The corpus callosum is thin or absent. Sometimes midline 
calcifications are described. There are multiple heterotopia of the olives. Microscopically the 
grey mantle in agyria can be divided into four layers: the (1) molecular, (2) superficial cellular, 
(3) cell-sparse and ( 4) deep cellular layers (see Figure 5 in Chapter 3). The molecular layer is 
slightly thicker and more cellular in agyria than in a normal brain. The superficial cellular layer 
contains pyramidal and polymorphic cells identical to the normal cell layers III, V, and VI, but 
reduced in number. In pachygyria the superficial cellular layer contains two additional cellular 
sublayers: a narrow layer of small pyramidal neurons, identical to normal layer ll and a deeper 
sublayer of small granular cells identical to normal layer IV. The cell sparse layer as well as the 
deep cellular layer are wider in agyria than in pachygyria and absent in the normal brain. The 
deep cellular layer contains non- or partially migrated neurons radially aligned in columns. This 
type of neuronal migration disorder is one of an extreme regularity. The pathologic layers are 
lying at regular distances of the cerebral surface, resulting in subsurface lines. Stewart et al. 
noticed that most reported cases of lissencephaly had a similar topographic distribution with an 
occipital predominance of agyria and some sulci present in the frontotemporal areas. He 
suggested that the cell-sparse zone was due to laminar cortical necrosis, resulting from hypoxia 
or perfusion failure. This would perhaps explain why agyria was found more often in the 
parieto-occipital watershed area, where ischaemia might be more severe than elsewhere. The 
cerebral peduncles, corticopontine and corticospinal tracts are small. The olivary nuclei are seen 
partly in their normal location, with heterotopic cell groups located in their migration pathway. 
The cerebellum is smaller than normal. The external granular layer of the cerebellum is absent. 
There are no Purkinje cell heterotopia. 
The ratio of heterotopic neurons to those in the superficial cellular layer suggests that in 
lissencephaly migration is arrested at some time during the process. In agyria, there is a 
disturbance during stage III of neocortex formation, between the 11th and 13th gestational 
week. In pachygyria the disturbance occurs in early stage IV of neocortex formation, around or 
after the 13th week of gestation. In addition, absence of the claustrum, heterotopia of the 
olivary nuclei and hypoplasia or absence of the corpus callosum are developmental disturbances 
occuring between the 11th and 14th week [105], and so confirming their association with 
lissencephaly. 
A quantitative analysis of the cell-densities of the cerebral cortex in a case of lissencephaly, 
showed that the total number of nerve cells was only slightly reduced compared to the normal 
brain.[101] In 1984 the above described form of lissencephaly was called classical or type I 
lissencephaly.[34] In contrast, type II lissencephaly shows complete loss of horizontal 
lamination.[34] In 1942 Walker reported such a patient with agyria and other abnormallities: 
hydrocephalus, microphthalmia and retinal dysplasia.[123] Microscopically the cortex was made 
up of masses of irregularly arranged cells. The cerebellar peduncles were small, the pyramids 
were practically absent and the inferior olivary nucleus was seen as an irregularly convoluted 
mass. In lissencephaly type I the migration to the neocortex and to the corpus pontobulbare is 
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especially disturbed. The involvement of the other major pathways of migration, namely in the 
cerebellum and to the corpus gangliothalamicum is relatively small. In type II lissencephaly glial, 
vascular and mesodermal proliferation is found in addition to migration disturbances.[37] 
Microgyria refers to small gyri.This term is synonymous with polymicrogyria. Histological 
abnormalities in layer formation are seen, showing four layers. The etiology of polymicrogyria 
is heterogeneous. 
CLASSIFICATION AND CLINICAL SIGNS 
The first two cases of lissencephaly were reported by Erhardt [43] and Culp.[21] They 
described two cases, one of which had been described before by Matell.[74] Matell described 
a brain which has to be classified with our present knowledge in mind as a combination of 
pachygyria and polymicrogyria. The patient was a microcephalic 27 year old woman, who had 
suffered from seizures since the age of two years. She learned to read and write, but soon lost 
these capabilities. She died from a status epilepticus. Most of the later publications - until1970 
-are case reports, in which lissencephaly was diagnosed at autopsy.[9,20,28,41,57,63,65,69,81,126] 
The children were microcephalic, severely retarded, and suffered from seizures; most of them 
died before the age of two years, often from pulmonary tuberculosis or another infection. Their 
brains were small showing agyria or pachygyria, absence of the claustrum and capsula extrema, 
sometimes absence or hypoplasia of the corpus callosum and heterotopia of the inferior olives. 
Six patients became older, 5 to 11 years of age; they showed pachygyria rather than agyria. 
Kulczycki described four patients: a girl of 4 months with agyria, a girl of 6 years with 
pachygyria and two patients with focal polymicrogyria, a man of 53 years old and a boy of 5 
years old. 
In 1963 Miller reported two siblings with lissencephaly whose parents were not consanguineous. 
Both children, a girl and a boy, were microcephalic and had similar dysmorphisms of the face. 
They were cyanotic, failed to thrive and were retarded in motor development. The girl died at 
the age of 3 months, the boy at 4 months. Autopsy showed in addition to the lissencephaly 
abnormalities of heart, kidney and gastrointestinal tract. In 1969 Dieker et al. described a 
'lissencephaly syndrome' in four patients, resembling the patients reported by Miller. These four 
patients included two described previously.[24] One case was sporadic, but the other three were 
related, two brothers and a female cousin. 
Jellinger and Rett [61] described the clinical features of four patients with agyria, three with 
pachygyria and one with a combination of agyria and pachygyria. All except one were 
microcephalic, and had mental retardation, facial anomalies, feeding difficulties, hypotonia and 
subsequent seizures. They postulated several possible etiologic factors in lissencephaly, either 
hereditary, environmental or an intrauterine perfusion disorder. In 1978, two sisters were 
described with lissencephaly.[48] The diagnose was made at autopsy in the first, and in the 
second child by the CT scan. The term 'Miller-Dieker Syndrome' (MDS) was introduced, to 
distinguish the so-called autosomal recessive form of lissencephaly from other types of 
lissencephaly.[62] The clinical manifestations of the MDS are the following: polyhydramnios, 
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postnatal growth deficiency, profound mental retardation, early hypotonia, later hypertonia, 
opisthotonus, seizures, microcephaly, relatively high forehead, bitemporal hollowing, wrinkling 
of the forehead, wide nasal bridge, epicanthal folds, anteverted nares, micrognathia, ear 
anomalies, cardiac defects, polydactyly, syndactyly, and other visceral anomalies. In 1984 Dobyns 
et al. began classifying lissencephaly and separated classical or type I lissencephaly from type 
II lissencephaly. 
All patients with the Miller-Dieker Syndrome (MDS) have a type I lissencephaly. Patients with 
only a type I lissencephaly without facial dysmorphisms or other somatic abnormalities as 
described in the MDS are classified as Isolated Lissencephaly Sequence (ILS). Dobyns 
proposed a severity scale for lissencephaly type I. Grade 1 meant no sulc~ grade 2 some sulci 
visible and grade 3 a mixture of agyria and pachygyria. All MDS patients apparently had a 
lissencephaly grade 1 or 2.[33] However other authors disagree and include also patients with 
focal pachygyria and polymicrogyria in the MDS.[2,120] 
Some patients with lissencephaly type I do not fit in either the MDS or the ILS.[1,67,91,98,100] 
They are actually classified as lissencephaly type I in association with: spastic paraplegia, 
turricephaly, hare lip, spina bifida, club feet, hypertelorism, abnormally high crossing of the 
pyramidal tract, hypodontia and a polyarthritis-like condition. This might be a heterogeneous 
group of patients, which needs further classification. Lissencephaly type I and a normal 
brainstem (without heterotopia of the olives) was described by Norman et al in 1976.[85] 
Dobyns et al.[33] proposed to use the eponym Norman-Roberts for this syndrome, despite the 
absence of more reports of this condition. It is further important to realize that some cases 
reported as lissencephaly are related to intra-uterine cytomegalovirus infection. These patients 
show diffuse calcifications with polymicrogyria.[85] 
Type II lissencephaly is combined with hydrocephalus, sometimes an encephalocele, and 
abnormalities of eyes and muscles. Dobyns et al.[34] initially proposed the eponym (after the 
first two authors) Walker-Warburg Syndrome (WWS).[123,124,125] Familial recurrence was 
reported by Chemke et al.[14] and by Pagan et al.[90]; the latter introduced the term HARD 
+ /- E syndrome (Hydrocephalus, Agyria, Retinal Dysplasia, with or without an Encephalocele). 
Krijgsman et al.[68] and Damska et al.[22,23] reported the combination of lissencephaly type 
II with congenital muscular dystrophy; it was named COMS (Cerebro-Oculo-Muscular 
Syndrome). In a recent review the diagnostic criteria for the autosomal recessive Walker-
Warburg syndrome were expanded with congenital muscular dystrophy and cleft lip or 
palate.[39] Another syndromal combination of lissencephaly is the autosomal recessive 
Fukuyama-type Congenital Muscular Dystrophy (FCMD). It was originally reported almost 
exclusively in Japan.[47] It shows widespread pachygyria combined with polymicrogyria and 
small areas of agyria. There are some other rarer forms of lissencephaly: 
Cerebra-Cerebellar-Lissencephaly (CCL) [6,33], and the Neu-Laxova-Syndrome (NLS).[33] 
Both syndromes probably have an autosomal recessive inheritance. 
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GENETIC STUDIES 
Initially, MDS was considered to be an autosomal recessive disorder. The observation of an 
enlarged short arm of chromosome 17 (17p) in unhanded metaphases of one child was at that 
time interpreted as a normal variant, also occurring in the healthy father and some other 
relatives.[30] Jellinger and Rett [61] subsequently also found a slight enlargement of 
chromosome 17p in a patient with lissencephaly; the significance of this fmding remained 
unexplained. In 1983 Dobyns et al. described a ring chromosome 17 in one patient with MDS 
and in another a partial monosomy 17p13. using high-resolution banding. In a review of 
lissencephaly type I, Stratton [111] proposed that monosomy 17p13.3 was the possible cause of 
the MDS in eight patients instead of an autosomal recessive inheritance. Six additional MDS 
patients with a deletion of 17p were described.[10,49,51,52,104] However some MDS patients 
had no microscopically detectable deletion of 17p even in high resolution banding preparations 
[31], which might suggest a submicroscopical deletion. The relation between microscopical and 
submicroscopical deletions in MDS was addressed by Van Tuinen et al.[l19] and Schwartz et 
al.[103,119] A molecular dissection of the critical region of 17p, was done using a human cell 
panel, including hybrids obtained from three MDS patients. Three DNA markers, YNZ22.1 
(D17S5), YNH37.3 (D17S28), and 144-D6 (Dl7S34), were deleted in four patients with 
microscopically visible deletions. Two MDS patients with normal chromosomes also showed 
deletions for the probes YNZ22.1 and YNH37.3.[103] The latter findings were confrrmed in 
three other MDS cases with normal chromosomes.[119] (Chapter 6) 
The cause of ILS is unknown, but probably heterogeneous. Proposed mechanisms were viral 
infection or maternal uterine bleeding during pregnancy [32], attempted abortion [20], or 
medication.[75,87] There is one report of a family with three affected brothers with ILS.[93] 
Autopsy was performed in one patient and was typical for type I lissencephaly grade 3, except 
for the unusual six-layered cortex in temporal and occipital regions, and the absence of olivary 
heterotopia. Another ILS patient with a lissencephaly grade 2 was born from first cousins. 
Descriptions of affected sibs of type I lissencephaly with unusual associated signs might also give 
the impression of an autosomal recessive inheritance.[1,85,91,98] Another hypothesis is a 
deletion within the critical region for the Miller-Dieker syndrome. This may fit in the concept 
of a contiguous gene syndrome, where the cause of ILS is hypothesized to be the expression of 
involvement of less genes than in the MDS.[106] It is likely to suppose a gradual transit from 
lissencephaly grade 1 to 4. However, until now no deletion at the chromosomal or DNA-level 
has been found in patients with ILS. 
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Chapter I 
EPIDEMIOLOGY 
Epidemiologic data on lissencephaly are not available. Crome [20] observed ten cases of 
polymicrogyria and two of pachygyria in a consecutive autopsy series of 137 microcephalic 
brains. Untill recently, no large series of lissencephaly were described.[40] 
This raises the impression that lissencephaly is a rare disorder. 
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Chapter 2 
EPIDEMIOLOGY OF liSSENCEPHALY TYPE I 
INTRODUCTION 
Lissencephaly is a rare developmental disturbance of the cerebral cortex, with either an absence 
or reduction of cerebral sulci. When the dev,elop!llental disturbance manifests in early pregnancy 
(11th-13th week) the sulci are lacking, and when it occurs by the end of the 13th week 
pachygyria results. In the normal situation more than 30 sulci are present in the newborn.[15] 
The amount of sulci in lissencephaly is expressed in grades 1 to 4, grade 1 meaning no sulci and 
grade 4 about 10 sulci.[26,33] The development of the Sylvian fissure is always disturbed in 
lissencephaly. Two types (I, II) of lissencephaly, are recognized.[32] In type I, facial 
dysmorphisms (bitemporal hollowing, midfacial hypoplasia, short nose with upturned nares, 
micrognathia, and furrowing of the forehead) is seen in varying degrees.[38] These patients 
exhibit the Miller-Dieker Syndrome (MDS), caused by a (submicroscopical) deletion of the 
short arm of chromosome 17 [71]; the others have the Isolated Lissencephaly Sequence (ILS) 
or unclassified forms. In type II lissencephaly, hydrocephalus and dysgenesis of the cerebellum 
are also present in combination with abnormalities of the eyes and muscles. 
The diagnosis of lissencephaly during life is based upon CT or MR scan findings by using the 
criteria described by Dobyns and McCluggage (1985).[36] The prevalence of and the risk 
factors for lissencephaly are largely unknown. This study tries to establish the prevalence at 
birth of lissencephaly type I in the Nether lands during 1980-1988. The determinants in time and 
space, the duration of survival and possible predictors of survival are also studied. 
MATERIAL AND METHODS 
Data collection 
From March 1986 until December 1989 all patients with lissencephaly in the Netherlands were 
searched for. This was achieved by individually questioning all child neurology departments, the 
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clinical genetic centres, and institutions of the mentally retarded. With the parent's consent, 
medical records were obtained and all patients were examined. In this way 51 possible cases 
were notified, of whom 22 fulfilled the criteria for lissencephaly type I, and became the subject 
of this study. 
Diagnosis 
All diagnoses were reanalysed by reviewing the CT or MR scan or data obtained at autopsy. 
The diagnosis was made by CT scan in 20 patients and by autopsy in 2 patients. Depending on 
the number of macroscopically visible sulci, patients were divided into two groups: 11 patients 
with a grade 1 or 2 (complete agyria and almost complete agyria), and 11 patients with a grade 
3 or 4 (combination of agyria with pachygyria and complete pachygyria) lissencephaly. 
Data analysis 
Data on 22 patients with lissencephaly type I were collected. Three cases born before 1980 were 
excluded when calculating the prevalence at birth1 because criteria for CT scan diagnosis of 
lissencephaly were not described before 1979.[48] In 16 (73%) of the total series of22 patients, 
the diagnosis was made before the age of 13 months. In 16 (84%) of the 19 patients born after 
1980, the diagnosis was made before the age of 13 months. Therefore, in calculating the 
prevalence at birth at least one year of follow-up was necessary. Patients born after January 
1989 were excluded for this reason. The prognosis for survival is based on all patients who 
entered the study, regardless of their date of birth. The 5 year survival rate was calculated by 
hand according to Kurtzke et al.[70] Patients were observed until death or as long as they were 
alive during the follow-up period, varying from 1 month to 10 years and one month (mean: 5 
years). No patients were lost in the study and 110 patient years could be observed. 
Clinical characteristics 
The criteria from Dobyns et al.[32] were used to classify the patients. Four patients were 
classified as having the Miller-Dieker Syndrome, the remainder (18 patients) as having the 
Isolated Lissencephaly Sequence. The clinical characteristics of 21 patients in this series have 
been described earlier.[26] In three of the MDS patients a small deletion of the short arm of 
the chromosome 17 was searched for and confirmed.[27] 
Family histories 
Family histories were detailed for three generations, with special attention to epilepsy, neural 
tube defects, leukaemia and breast tumours. The latter information was sought because of the 
localisation of oncogenes, related to leukaemia and breast tumor, in the close vicinity of 17 q21-
22 and 17p13.3 on chromosome 17.[25,73] This was done by questioning the parents. The 
results were compared to the prevalence in the Dutch population.[44] 
12 
RESULTS 
Prevalence 
The overall prevalence at birth of lissencephaly type I in the 
Netherlands in the period 1980 until1988 amounts to 12 per 
million births (Table 1). The 22 patients with lissencephaly 
consisted of 11 males and 11 females. 
Determinants in space 
The majority of patients were living in the most densely 
populated areas of the Netherlands. 
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Table 1. Prevalence of lissencephaly 
type I per 1000.000 births in the 
Netherlands. 
Year Female Male Total 
1980+1981 8.3 5.5 13.8 
1982+1983 8.7 11.6 20.3 
1984+1985 0.0 2.8 2.8 
1986+1987 10.7 2.7 13.4 
1988 0.0 5.3 5.3 
Survival 1980-1988 6.5 s.s 12.0 
The 5 year survival rate of patients in this study was 74% 
(Table 2). No data about the 5 years survival rate in patients with lissencephaly were available 
in the literature. Patients with the MDS often die before the age of 2 years, but patients with 
ILS may live longer.[38] In this study 7 
Table 2. Life table for patients with lissencephaly type I born patients died at ages from one month to 9 
in the Netherlands. years, with a mean of 3,5 years. The causes 
of death were intractable seizures or Years N Deaths WA At risk Pd 1-Pd Cum. 1-Pd infections. 
0-1 22 3 0 22.0 0.136 0.864 0.864 
1-2 19 0 1 18.5 0.000 1.000 0.864 Predictors of prognosis 
The 5 year survival of the 11 grade 1/2 
2-3 18 0 2 17.0 0.000 1.000 0.864 patients is 54% against 91% for the 11 
34 16 1 2 15.0 0.067 0.933 0.806 grade 3/4 patients (Figure 1). The severity 
4-5 13 1 1 12.5 0.080 0.920 0.741 
of the lissencephaly clearly determined 
prognosis, with a tendency towards a 
5-6 11 0 1 10.5 '0.000 1.000 0.741 longer survival in the grade 3/4 patients. 
6-7 10 1 3 8.5 0.118 0.882 0.653 Family histories 
7-8 6 0 1 5.5 0.000 1.000 0.653 No abnormal prevalences were found for 
8-9 5 0 3 3.5 0.000 1.000 0.653 epilepsy, leukaemia, and breast tumours. A high prevalence ( 4 cases) of spina bifida in 
9-10 2 1 0 2.0 0.500 0.500 0.328 the families was suggested, but only among 
10-11 1 0 1 0.5 0.000 1.000 0.328 third degree relatives. Parental 
consanguinity as established by the family 
N : number of patients history method was not observed in this 
WA : withdrawn alive study. There were no recurrences among 
Pd : proportion of death siblings. However, within the 22 families 1-Pd : proportion of surviving 
only 9 healthy children were born after the Cum. 1-Pd : cumulative survival 
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birth date of the patient; the total number of 
siblings of patients was 17. 
The paternal age ranged from 21 to 42 years with 
a mean of 30,7 and a median age of 30. The 
maternal age ranged from 17 to 40 years with a 
mean of 28,6 and a median of 29. The mean pater-
nal age for the general population in the 
Netherlands is 30 years, and the mean maternal age 
is 28 years.[44] 
DISCUSSION 
There are no exact data on the prevalence of 
lissencephaly type I. Dobyns reported about 100 
cases from the literature.[38] Over 60 of these 
cases were type II lissencephaly. Other publications 
deal with 39 additional cases with lissencephaly type 
1.[12,29,49] The present study revealed for the first 
time a prevalence at birth of 12/1000.000, for the 
type I lissencephaly. Recent data from a regional 
registration in Europe of congenital malformations 
[44] gave a prevalence of 5,5/1000.000, for 
Figure 1: Survival for patients with grade 1/2 
lissencephaly and grade 3/4 lissencephaly. 
Number of survivals in parenthesis 
Cum.1-Pd 
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lissencephaly of unidentified type. In a rare disorder, the completeness of ascertainment in a 
population may be expected to rely upon completeness of, diagnosis, referral and reporting, the 
availability of CT scans and the autopsy rate in mentally retarded children. In the past only one 
pathology study mentioned 2 brains with pachygyria in a series of 137 microcephalics.[20] 
Patients with a grade 1/2lissencephaly have a worse prognosis than grade 3/4 (Figure 1). This 
might be expected, from the more severe disturbance of the cortex in grade 1/2lissencephaly 
as compared to grade 3/4lissencephaly. The family histories of lissencephaly patients showed 
a relatively high number (n=4) of spina bifida patients in third degree relations. This seemed 
noticeable, since only 3 relatives with epilepsy, a much more common disease, were mentioned 
in these families. However, the occurrence of spina bifida only in third degree relatives reduces 
the likelihood of a relation between neural tube defects and lissencephaly. Embryological 
insights [122] make a relation between neural tube defects and neuronal migration disorders 
unlikely. 
The etiology of lissencephaly type I is generally unknown. No intoxications during pregnancy 
were mentioned. Most of the patients with MDS have been related to a deletion of the 
chromosome 17p.[119] This can be caused by a spontaneous deletion, translocation in one of 
the parents [111] or a germ cell mosaicism.[54] In the ILS patients a chromosomal cause has 
so far not been found. 
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DIAGNOSTIC FEATURES 
AND CLINICAL SIGNS IN 21 PATIENTS WITH 
LISSENCEPHALY TYPE I 
INTRODUCTION 
There are at least two types of lissencephaly, 
according to Dobyns et al.[32], called type I 
and type II. This study is concerned mainly 
with type I (Table 1). 
Histology 
In type I lissencephaly (sometimes called 
classical four-layered lissencephaly) the 
neocortex formation is severely disturbed. This 
results in a cortex consisting, from inside to 
outside, of heterotopic non-migrated neurons, 
a cell-sparse layer, components of layer m, v 
Table L Classification of lissencephaly* 
Type I 
Isolated Lissencephaly Sequence [ILS] 
Miller-Dieker Syndrome [MDS] 
Non-classified forms 
Type II 
Walker-Warburg Syndrome [WWS] 
Fukuyama Congenital Muscular Dystrophy 
Non-classified forms 
Rare forms 
Neu-Laxova Syndrome [NLS] 
Cerebro-Cerebellar Syndrome [CCS] 
and VI combined, and a molecular layer. On * Dobyns et a!. 1984 [32] 
the outside there is agyria. In pachygyria, small -----------------
cellular II and IV layers are found.[llO] In agyria, neuronal migration is disturbed between the 
11th and 13th week of pregnancy, stage ill of neocortical development according to Sidman and 
Rakic.[105] Pachygyria is presumed to result from a disturbance of neocortex formation after 
the 13th week but before completion of neuronal migration (stage IV). Often agyria and 
pachygyria are combined in one brain. Type II lissencephaly is characterized by an almost 
complete absence of cortical layer formation. It features other cerebral malformations 
(hydrocephalus, Dandy-Walker malformation and disturbed myelination), combined with 
abnormalities of the eyes and the muscular system.[34] 
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Gross brain morphology 
In clinical studies the term 
lissencephaly is often used for both 
agyria (meaning no gyri) and 
pachygyria (meaning few and broad 
gyri). Dobyns et al.[33] proposed a 
classification of lissencephaly into 
Table 2. Classification of lissencephaly type I according to 
pathology and radiology* 
Grade 1: complete agyria 
Grade 2: agyria with some sulci 
Grade 3: a mixture of about 50% agyria and 50% pachygyria 
Grade 4: complete pachygyria 
three degrees of severity facilitating a • Modified after Dobyns et a!. (33] 
correlation of clinical fmdings 
according to pathology and radiology. Because of the close relation between 
pachygyria we have added pachygyria to this classification (Table 2). 
agyria and 
Figure 1. Patient 1, a boy with liS grade 4, age 3 years: high forehead 
only, no other facial dysmorphisms. 
Somatic and facial dysmorphology 
Lissencephaly type I, is classified 
as Miller-Dieker syndrome (MDS) 
if typical facial and somatic 
dysmorphic features are present 
and as isolated lissencephaly 
sequence if only secondary facial 
dysmorphisms are found. 
Sometimes patients with MDS lack 
somatic dysmorphic features. 
Cytogenetics 
In MDS a mini-deletion of the 
short arm of chromosome 17 is 
found on prophase chromosome 
analysis, but this deletion may be 
too small to be detected under the 
microscope. Detection of a 
deletion at the DNA-level in some 
cases [103,119] suggests that MDS lS always related to a deletion of the short arm of 
chromosome 17. 
Present study 
This study presents 21 children with lissencephaly type I, the largest series reported until now. 
The clinical characteristics are compared with 55 cases described with sufficient detail in the 
literature.[2,10,13,19,20,28,30,31,32,41,42,48,51,52,53,57,58,61,62,63,76,80,81,83,85,87,110,117, 
127,129] 
16 
PATIENTS AND METHODS 
A multicentre co-operative study was 
conducted with the co-operation of all 
child neurology departments in The 
Netherlands, so that a nation-wide survey 
of known children with lissencephaly type 
I (21 patients) could be made. 
Lissencephaly was diagnosed by autopsy 
(2 patients) or by CT scan (19 patients). 
More precise confirmation was obtained 
by MRI in five patients and by autopsy in 
another four. Thus the criterion for 
inclusion in the study was an abnormal 
CT or autopsy confirmation of 
lissencephaly type I. 
In diagnosing lissencephaly on CT scan, 
the criteria of Dobyns and 
McCluggage[33] were followed. In 
lissencephaly type I the brain surface is 
smooth and there is no Sylvian fissure, so 
the brain is shaped like a figure-8. At the 
same time there is a sharp demarcation 
between grey and white matter, 
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Figure 2. Patient 1: CT scan showing thick cortex with open 
Sylvian fissure and colpocephaly: some sulci are visible. 
depending on the severity of lissencephaly. In complete agyria there are no sulci; in grade 2 four 
sulci are visible, at most; in grade 3 four to six sulci are found, with sometimes a beginning of 
the formation of the Sylvian fissure. In pachygyria at most ten sulci are seen in all the regions 
of the brain, but clearly less than the normal number. In all CT scans, the grey matter is 
relatively enlarged and colpocephaly is seen. Corpus callosum hypoplasia is variably present and 
occurs mostly in lissencephaly grade 1 and 2. Representative cases are described below. 
Case reports 
Patient I 
This boy with ILS grade 4 (pachygyria) was the second child of unrelated parents; their first 
child was a healthy girl. He was born at term after an uneventful pregnancy and delivery. His 
length, weight and head circumference were all on the 50th percentile. His development at the 
age of 10 weeks seemed to be retarded. An EEG at four months showed unusually high 
voltages in the beta frequencies. At the age of eight months a CT scan was interpreted as 
showing cortical atrophy, with widened ventricles. A second EEG at the age of 13 months 
showed diffuse beta activity of high voltage. At the age of 25 months the boy had periods of 
head-banging, jerking and losing contact with his environment. He was treated with sodium 
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chromosome 17pl3.3. The karyograms of the 
parents were normal. The girl is now 36 months 
of age and she has frequently suffered 
respiratory tract infections. Generalized seizures 
started at the age of six months, which are at 
the moment reasonably well controlled with 
phenobarbital and phenytoin. Her development 
does not improve; she has no head control and 
there is no visual tracking. 
Patient 21 
This girl with clinical MDS but no 17p deletion 
was the first-born of parents who were related 
10 generations ago. Two children with a spina 
bifida had been born in the father's family. The 
pregnancy was complicated by slight 
hypertension. The girl was born, without 
complications, at 41 weeks. Head circumference, 
weight and length were on the 50th percentile. 
Apart from two sacral dimples, there were no 
other abnormalities. At age three months there 
was no ocular fixation or tracking, there was 
head-lag and hypotonia with extensor plantar 
reflexes. Routine blood, urine and cerebral 
spinal fluid analyses were normal. There were 
no signs of congenital infections. cr showed 
classical type I lissencephaly with colpocephaly 
Figure 5. Patient 2: abnormal cerebral cortex with 
layer of ganglion cells (a) followed by cell-sparse layer 
(b) and colums of non-migrated neurons (c) (Bodian 
staining). 
and a complete lack of sulci. High-resolution chromosome studies in the prophase were normal. 
Later, the girl had periods of jerking, especially of the arms, for which she was treated with 
phenobarbital. At age 25 months she still had severe head-lag, did not roll over, and made only 
little eye contact. Her head circumference was 45 em; she had become microcephalic, with 
bitemporal hollowing and retrognathia. 
RESULTS 
The diagnoses of the patients studied in our series and those previously described are 
summarized in Table 3. To allow comparison of diagnostic techniques, we separated patients 
studied with standard chromosome banding techniques from those analyzed with high-resolution 
techniques. All the chromosome deletions were found in MDS patients. Table 4lists the clinical 
signs in the patients studied in the present series. Ten patients had lissencephaly grade 1 or 2, 
four of whom had MDS. The other 11 had lissencephaly grade 3 or 4 (six grade 3, five grade 
20 
Chapter 3 
Figure 6. Patient 7, a girl with MDS: peculiar face with a high forehead, bitemporal hollowing, and micrognathia. 
4). Table 5 compares the clinical fmdings of the ILS 
patients with proven normal prophase chromosomal 
studies from Table 3 with those of patients who had a 
deletion of the short arm of chromosome 17 (our study 
and the literature combined). We did this to compare 
the clinical signs of patients with lissencephaly, with and 
without microscopically visible chromosome 17 deletion. 
Patients with a 17p deletion have more facial 
dysmorphisms than those with lissencephaly without 17p 
deletion. Table 6 summarizes the somatic abnormalities 
in patients with 17p deletion. Table 7 compares ILS 
patients with and without prophase chromosomal 
studies in this series with patients described in the 
literature. The most striking feature is that 
microcephaly does not always occur. 
In the literature, only 18 patients with MDS had a 
proven deletion of chromosome 17p, but chromosome 
studies were inadequate for 14 of the other patients 
with clinical MDS. Two patients have been described 
with MDS and normal chromosomes studied in the 
prophase: these are patients 2 and 6 of Dobyns et 
Figure 7. cr scan of patient 7: no sulci, 
characteristic f"IgUre-of-eight appareance, 
with colpocephaly. 
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al.[32] Patient 2 was considered to have MDS, although 
the features were less pronounced than in other cases and 
there were no other somatic abnormalities.[31,32] Patient 
6 was the only MDS patient without microcephaly.[32] 
There were two MDS patients in our series (13 and 20) 
with normal chromosomes in the prophase. We also 
classified patients 7, 14 and 20 as MDS, because patient 7 
had syndactyly of the toes, patient 14 had corneal clouding 
and patient 20 had two sacral dimples, beside the 
lissencephaly. In addition to these somatic abnormalities, 
these patients had clearly dysmorphic faces. Patient 13 was 
classified as MDS because of severe facial dysmorphism, 
but without other somatic abnormalities. 
Table 3. Patients diagnosed on basis of 
clinical signs 
Present Literature 
series 
II.S patients 17 (13)* 21 (2) 
MDS patients 4 (3) 34 (20) 
Deletion 17p 1 18 
• Numbers in parentheses indicate 
patients studied with high resolution 
chromosome binding. 
Table 4. Clinical aspects of patients. 
--~M~o~s~---,r0~~~~--------~~~~77------
Case number 
Age (mths) last report 
Age (mths) last seizure 
Epilepsy < 6 mths 
Infantile spasms 
Growth deficiency 
Recurrent infections 
Hypotonia 
Spasticity 
Microcephaly 
Bitemporal hollowing 
Micrognathia 
Malformed ears 
Karyotype in prophase 
• These patients have died 
•• 46XX 17p-; 
- 46XY; 
# 46XX 
DISCUSSION 
7 13 14 20 
36 611* 25 
6 6 1 3 
+ + + + 
- - - -
+ - + -
+ 
- + + + 
+ -
+ + + + 
+ + 
-
+ 
+ + + -
- + + -
- - # 
Four main points for discussion emerge from this study. The first is that ILS is apparently much 
more common than MDS in the present study. Only two other studies suggest this [29,49], but 
neither study permits division into grades 1 to 4. The second point is that there tend to be more 
severe abnormalities in gross brain morphology in MDS than in ll-S. All patients with MDS in 
our study and all except one in the literature [110] had lissencephaly grade 1 or 2, whereas in 
ll-S the grades are from 1 to 4. The less severe grades probably occur more often than has been 
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supposed hitherto. The third point concerns the clinical picture, about which the following 
observations can be made. 
Table 5. Clinical signs of patients with prophase chromosomal studies in present series and literature. 
17p deletion ILS grades 1 + 2 ILS grades 3 + 4 
(N=19) (N=7) (N=9) 
Age (mths) last report (mean) 5-54 (21) 2-99 (46) 7-93 (57) 
(N=7) (N=6) (N=8) 
Age (mths) at death (mean) 3-47 (13) 6 7 
(N=12) (N=1) (N=1) 
Retardation 19 7 9 
Age (mths) first seizure (mean) 0-7 (3) 1-6 (4) 1-39 (10) 
Epilepsy < 6 mths 12 5 6 
Infantile spasms 5 3 4 
Growth deficiency 14 4 5 
Recurrecent infections 8 2 3 
Hypotonia 13 3 5 
Hypertonia 12 4 4 
Microcephaly 19 7 6 
Bitemporal hollowing 14 5 1 
Micrognathia 17 3 2 
Malformed ears 16 3 0 
Pregnancy 
Polyhydramnios was only noticed twice in the group of lissencephaly patients described in this 
study. Maternal age at the time of delivery was between 17 and 40 with a mean of 28 years. 
Facial dysmorphisms 
Dobyns et al.[32] were the first to describe ILS. According to those authors, facial dysmorphism 
is less conspicuous in patients with ILS than in those with MDS, who also have more specific 
facial dysmorphisms, like wrinkling of the forehead. In our study, facial dysmorphism was seen 
most frequently in MDS patients, followed by grades 1 and 2 ILS and finally by grades 3 and 
4 ILS. However, no facial dysmorphism was specific to MDS. Microcephaly is almost always 
present in MDS and lissencephaly grade 1 and 2. All of our MDS patients were microcephalic, 
and in the literature, there are only three patients with lissencephaly grade 1 and 2 who were 
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not microcephalic (patient 1 of Harper [58]; patient 6 of 
Dobyns et al. [32], patient 2 of Motte et al.[80] Only one Table 6. Somatic signs of 19 patients 
with a deletion 17p. 
patient with lissencephaly grade 4 was not microcephalic 
(patient 6 from Jellinger and Rett.[61] From the present 
study, it appears that 36 percent of patients with lissencephaly 
grades 3 and 4 might not be microcephalic. Remarkably few 
ILS patients reported by Gastaut et al.[49] and Dhellemmes et 
al.[29] were microcephalic: five of 14 (36 percent) in the 
former study and three of 10 (30 percent) in the latter. This 
suggests that those two studies included more patients with 
lissencephaly grades 3 and 4 than with grades 1 and 2. 
We conclude that neither microcephaly nor facial dysmorphism 
Malformed fingers 
Congenital heartdefect 
Sacral dimple 
Cryptorchidism 
Malformed kidneys 
Corneal clouding 
Duodenal atresia 
N 
8 
8 
7 
4 
3 
1 
1 
can be considered specific to either MDS or ILS, but microcephaly in combination with facial 
abnormalities should increase suspicion of MDS. 
Distinction between ILS and MDS 
It is clear from Table 3 that our series contains more ILS patients with adequately performed 
chromosome analysis, whereas the literature contains many more MDS patients. Only two 
patients with ILS and normal chromosomes in the prophase have been well described (patients 
7 and 8 of Dobyns.[32] We describe 13 patients with clinical ILS and normal prophase 
chromosomal studies. The distinction between ILS and MDS is made on clinical grounds, 
because MDS patients have more facial dysmorphisms and in most cases also have somatic 
abnormalities. 
Tabel 7. Clinical signs of ILS patients in present series and in literature. 
ILS grades 1 + 2 ILS grades 3 + 4 
Present series Literature Present series Literature 
(N=6) (N=l3) (N=ll) (N=8) 
Retardation 6 13 11 8 
Age 1st seizure (mean) 1-6 (4) 0-18(16) 1-39 (9) 0-36 (8) 
Epilepsy < 6 months 6 8 8 6 
Infantile spasms 3 8 4 3 
Growth deficiency 3 3 4 2 
Recurrent infections 3 5 4 3 
Hypotonia 4 3 7 3 
Spasticity 2 6 6 5 
Microcephaly 6 11 7 7 
Bitemp. hollowing 2 7 1 1 
Micrognathia 0 4 1 1 
Malformed ears 1 2 0 0 
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Age 
Patients with lissencephaly 
may live longer than was 
previously thought. Our 
oldest patient died at the age 
of 10 years, and , six other 
patients were aged six years 
or more. It has been thought 
that the majority of these 
children will die before the 
age of two years. 
Retardation 
All the children in this study 
were severely retarded. 
Those with lissencephaly 
grades 1 and 2 are 
bed-bound and have little 
Chapter 3 
contact with their environment. Patients with a grades 3 and 4 also are severely retarded but 
have some contact with their environment, and some are able to crawl. The majority cannot 
speak, but some of the patients with a pachygyria can say one or two simple words. These 
findings are in agreement with other reports in the literature. 
Epilepsy 
Eighteen of our 21 patients (86% percent) developed epilepsy early, before the age of six 
months, and about one-third have infantile spasms. Patients with lissencephaly grades 3 or 4 
may have their first epileptic attack later than those with grades 1 or 2. It is important to realize 
that the absence of epilepsy does not exclude lissencephaly, but lissencephaly without epilepsy 
is uncommon. These patients' EEGs showed some more or less characteristic patterns.[27] The 
different occurrences of microcephaly and epilepsy may be explained by the difference in 
relative frequency of lissencephaly grades 1 and 2 compared with grades 3 and 4, in the 
literature and in our series. We presume that grades 3 and 4 has been under-represented in the 
literature published so far. As long ago as 1956, Crome suspected that pachygyria would be 
much more frequent than agyria, but this has never received much attention in clinical studies. 
The fourth main point for discussion referred to above is the chromosomal and genetic aspects. 
We were interested to correlate the size of the deletion in MDS with the clinical symptoms. 
There are 19 well-described patients with a deletion of chromosome 17p (Table 3), 18 in the 
literature and our patient 7. Their somatic abnormalities are shown in Table 6. Thirteen of 
these patients had an unbalanced translocation, two had a ring-chromosome and only four had 
an isolated deletion of the short arm of chromosome 17. This situation makes it difficult to 
describe the signs of an isolated deletion of 17p. Of the four patients with an isolated 17p 
deletion, two had a deletion of 17pl3. (patient 1 of Bordarier et al.[10]; patient 1 of Cordes et 
al.[19] The third as patient 5 of Dobyns et al.[32] and Stratton et al. [111], and the fourth was 
our patient no. 7 (see case report). Chromosome analysis of Dobyns and colleagues' patient 5 
showed a deletion of 17p13.1 [111], and in our patient 7 there was a deletion of 17p13.3. Patient 
5 described by Dobyns [32] and the patient described by Bordarier et al.[10] had a sacral sinus 
in addition to the lissencephaly. The patient described by Cordes et al.[19] showed bilateral 
cryptorchism in addition to lissencephaly. These signs are very non-specific. More case histories 
are needed to establish the minimum number signs caused by the smallest possible deletion of 
17p13.3 associated with lissencephaly. 
In our study, the chromosomes of the parents of three MDS patients were normal. Patients with 
clinical MDS and normal prophase chromosomes are mentioned in the literature, but not 
extensively described, and they may have had a submicroscopical deletion. This may also apply 
to patients 13 and 21 in our study, who both fitted the MDS criteria. In future, DNA analysis 
may detect these hidden deletions.[103,119] Patients with lissencephaly grades 1 or 2 and 
submicroscopical deletion of chromosome 17p may have few symptoms of MDS, so some cases 
classified as ILS may prove to be MDS after DNA analysis. In the literature one patient with 
a deletion 17p in prophase chromosome analysis did not have somatic abnormalities (patient 
2 of Garcia et al.[48] This stresses the need for further investigations to facilitate separation 
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of these two conditions. The occurrence of ILS has been considered an isolated event and no 
family with more than one child with ILS has been found. Consanguinity between parents of 
an ILS patient was mentioned by Dobyns [37], and he suggested the possibility of autosomal 
recessive transmission. More family studies are needed in to judge the risk of recurrence of ILS 
in one family, but the data obtained in our series do not support the suggestion of an autosomal 
recessive transmission. 
Unclassified forms of type I lissencephaly 
Apart from MDS and ILS other conditions are known who feature lissencephaly type I together 
with other signs, as yet unclassified.[1,83,91,98] This is probably a heterogeneous group of 
patients. In addition to the lissencephaly type I, they had such signs as severe spastic paraplegia, 
hypertelorism, turricephaly, spina bifida, club feet, cleft palate and congenital nephrosis. 
Unfortunately none of these cases was studied with special chromosome techniques to detect 
a small deletion. 
We conclude that the diagnosis of lissencephaly can be made with confidence on combined 
clinical and neuroradiological grounds together. Moreover, clinical distinction between MDS and 
ILS is possible and most cases can be classified as one or the other before the results of the 
chromosome analysis become known. For the small group of patients for whom it is very 
difficult to decide, DNA analysis may offer the opportunity to make a more exact distinction. 
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Chapter 4 
EEG AND EVOKED POTENTIALS 
IN A SERIES OF 21 PATIENTS 
WITH LISSENCEPHALY TYPE I 
INTRODUCTION 
Lissencephaly is a disturbance in the neuronal migration toward the neocortex resulting in a 
total or partial absence of sulci. The patients are often microcephalic and always severely 
retarded. Epileptic seizures are common in early in life. Lissencephaly is subdivided into two 
types, I and ll.[32] Type I may be either an Isolated Lissencephaly Sequence (ILS) or 
lissencephaly combined with facial dysmorphisms and often somatic malformations 
(Miller-Dieker Syndrome, MDS). The latter is related to a deletion of the short arm of the 17th 
chromosome.[31] In lissencephaly type IT, other cerebral abnormalities such as hydrocephalus, 
Dandy Walker malformation and disturbed myelination are found combined with abnormalities 
of the eyes and muscles.[34] This study concerns lissencephaly type I only. Excluding our O'Wll 
series of 21 patients, as yet only 59 patients with lissencephaly type I have been described in 
detai1.[26] 
At present the diagnosis lissencephaly type I can be made by CT or MRI. In imaging studies 
as well as at autopsy the severity of lissencephaly type I is assessed in four grades ranging from 
grade 1 (complete agyria) to grade 4 (complete pachygyria).[26,33,35] The EEG in 
lissencephaly is the subject of only a few publications. Hypsarrhythmia was demonstrated 
[24,30,48,53,61] in ten cases. Only two of these patients suffered from infantile spasms. Dulac 
et al.[42] described four patients with agyria; two of them showed an alpha rhythm with high 
amplitude. In a larger series of 15 patients [44] all EEG's were characterized by fast activity 
with high amplitudes between 150 and 350u V. In young patients widely distributed theta activity 
was seen also, either alternating or mixed with this alpha and beta activity. The frequencies of 
the theta rhythms increased with age. Spike- and wave-complexes were seen also. Generally no 
reaction occurred on eye opening or on photic stimulation. Sleep had no influence on the 
EEG.[49] Hiura et al.[59] described the occurrence of REM sleep in 3 patients, albeit reduced 
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in comparison to normal subjects. Mizuguchi et al.[79] performed polysomnography in 2 
patients, showing highly abnormal sleep patterns. As far as we know, no studies exist on evoked 
potentials in lissencephaly. The aim of our study was the description of EEG's and evoked 
potentials as well as the extraction of neurophysiological features typical for lissencephaly, which 
eventually might be useful in the diagnosis of this disorder. 
MATERIAL AND METHODS 
Patients 
In the Netherlands a study was done 
in cooperation with all centres for 
child neurology. In this way a series of 
21 patients with lissencephaly type I 
was collected. In 19 patients the 
diagnosis was made by cr, in the 
other two at autopsy. The radiological 
diagnosis was confirmed by 
microscopy in 4 patients. Ten patients 
were classified as lissencephaly grade 
1 or 2 (complete agyria or some sulci 
present) and eleven patients were 
classified as grade 3 or 4 (mixture of 
agyria and pachygyria or complete 
pachygyria). Four patients had the 
Miller-Dieker syndrome, the others 
the ll.S form of the disease. All 
patients were severely retarded and 
had epilepsy. In 7 patients infantile 
Table 1. EEG patterns of 21 lissencephaly patients (Liss) 
compared to 21 patients with an atypical cortical dysplasia 
(A.C.D.) and a control group (Con.), consisting of 823 patients who 
underwent an EEG for various reasons. 
Liss A.C.D.Con. 
Number of BEG's 114 
Number of patients 21 
52 
21 
882 
823 
Percentage of BEG's 
Abnormal EEG 100#* 
Abnormal background pattern 95#* 
Generalized fast activity > SOu V 45#* 
Generalized fast activity > 150u V 25#* 
Generalized slow activity > 300u V 24* 
Asymmetrical background pattern 4 
Sharp- and slow-wave complexes >800uV 37#* 
Continuous epileptic activity 8* 
Alternating pattern•• 11#* 
#Fisher Exact test, p <0,05; Liss.tested against A.C.D. 
• Fisher Exact test, p < 0,0001; Liss.tested against Con. 
•• See text 
81 37 
76 23 
8 0.1 
2 0 
10 1 
0 9 
0 0.1 
2 0.3 
2 0 
spasms occurred. All patients were on anti-epileptic medication. Plasma levels were in the 
non-toxic range in all. Our 21 patients were compared to a group of 21 patients with an atypical 
cortical dysplasia different from lissencephaly. This is also called "pachygyric-like changes".[l16] 
In the latter group of patients the diagnosis was made on the cr scan and confirmed at 
microscopy in 4 patients. Epilepsy was seen in 11 of these patients; two patients suffered from 
infantile spasms. All patients with seizures used anti-epileptic medication. 
These two groups of patients (patients with lissencephaly or an atypical cortical dysplasia) were 
compared to a control group of 823 consecutive patients, seen at the department of Clinical 
Neurophysiology in the Juliana Children's Hospital. The reasons for the EEG in these patients 
were: (epileptic) seizures, retardation, trauma, infection, anoxia and headache. 
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Acquisition and 
analysis of EEG's and 
Evoked Potentials 
The EEG's were 
recorded in our ovv.n 
hospital or in the 
contributing centres. All 
EEG's were recorded 
with 16 or 21 channel 
EEG machines using 
several derivations. The 
technical quality of all 
recordings was 
according to the 
standards set by the 
IFSECN. In the 21 
lissencephaly patients 
114 EEG's were 
recorded (range: 2 to 11 
EEG's for each patient). 
The age of the patients 
at recording of the EEG 
was between 1 and 85 
months (median: 8 
months), 59% of the 
EEG's were made in 
the first year of life. In 
the group of 21 patients 
with another cortical 
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Figure 1-a. A girl with lissencepaly grade 3/4 at the age of 23 months; generalized 
fast activity with amplitudes of lSOuV. 
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dysplasia, 52 EEG's were reviewed. Fifty-eight percent of these recordings were done in the first 
year of life (the median age at recording was 7 months). In the control group 57% of the 882 
EEG's were recorded under the age of 12 months. Special attention was given to features of 
the background pattern, such as the amount of generalized fast and slow activity and 
asymmetries, and to epileptic activity i.e. sharp waves and sharp- and slow-wave complexes. An 
EEG was classified as continuously epileptic when epileptiform activity was seen throughout the 
entire period of recording. As some patients used medications knovv.n for enhancing fast (beta) 
activity, this EEG feature was taken into account only when amplitudes were higher than SOu V. 
Short latency somatosensory evoked potentials (SEP's) were recorded in 10 lissencephaly 
patients in our department. The median nerve was stimulated with electric pulses of 0,1 ms 
duration at a stimulus frequency of 5/s. The following derivations were used: point of Erb-Fz, 
Neck (at vertebra C7)-Fz, C3-A1 or C4-A2, C3-Fz or C4-Fz. In the first few children tested a 
derivation to a non-cephalic reference electrode was tried. Due to the many artifacts during 
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such recordings, this practice had to be abandoned in favor of the less sophisticated choice of 
Fz as a reference. The filters were set at 10 and 3000 Hz. Twohundred and fifty-six sweeps of 
50 ms duration were recorded with a stimulus delay of 12,5%. Automatic artifact rejection 
precluded severe distortion of the average obtained from these sweeps. 
Figure 1-b. A girl with lissencephaly grade 1/2 at the age of 12 months; sharp- and slow-wave complexes with 
amplitudes up to 2900uV. 
Br: 70 bz. 500uV 
IC: 1,2 .. c. 
1 MC. 
RESULTS 
The results of the assessment of the BEG's are summarized in Table 1. All BEG's of the 
lissencephaly patients and 81% of the BEG's of the patients with an atypical cortical dysplasia 
were abnormal. Striking features in the group of lissencephaly patients were: 
(a) generalized fast activity (8-18/s) with high amplitude (range 50-400uV), see Figure 1a. 
(b) continuous generalized slow activity with high amplitude (above 300uV) 
(c) sharp- and slow-wave complexes with high amplitude (range 500-3000uV), see Figure lb. 
(d) an alternating pattern consisting of bursts with a duration of several seconds consisting of 
sharp waves with amplitudes from 500u V to 2000u V alternating with relative depression of EEG 
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activity with amplitudes of lOOuV or less, see Figure lc. The patterns (a), (c) and (d) were 
found significantly more often in patients with lissencephaly than in patients with an atypical 
cortical dysplasia (Fisher Exact test p<0.05). These patterns, as well as pattern (b), were seen 
very seldom in EEG's recorded of patients suffering from other pathology (Fisher Exact test 
p <0.0001). 
Figure 1-c. A girl with lissencephaly grade 1/2 at the age of 19 months; an alternating pattern consisting of 
paroxysms of sharp waves for several seconds with amplitudes up to 2000uV alternating with periods of depression 
for several seconds. 
Hl• 70 Hz. 
B:C: 1.2 ••c. SOOuV 1-:1 ,-------
1 ••e. 
In 95% of the lissencephaly patients and in 82% of their EEG's pattern (a) or (c) or both were 
recorded, compared to only 5% of the patients with an atypical dysplasia (8% of their EEG's). 
In the control group pattern (a) or (c) were seen rarely (in 0,4% of the EEG's). In 11% of the 
EEG's recorded from the lissencephaly patients the alternating pattern (d) was seen, compared 
to 2% of the EEG's recorded from patients with an atypical cortical dysplasia. This pattern was 
absent in the control group. Recordings with pattern (a) followed by pattern (c) or vice-versa 
occurred in nine lissencephaly patients. In 3 patients a full cycle with return to the initial pattern 
was found (a)-( c)-( a) or (c)-( a)-( c). There was no clear relation between age at recording and 
one of the EEG patterns described. The differences between the group of lissencephaly patients 
grade 1 and 2 and the group with lissencephaly grade 3 and 4 can be seen in Table 2. 
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Generalized fast activity with high 
amplitudes was seen more often 
in lissencephaly grade 3 and 4. In 
contrast sharp- and slow-wave 
Table 2. Patterns in the EEG of lissencephaly patients. Lissencephaly 
patients with grade 1 and 2 compared to patients with grade 3 and 4. 
complexes with high amplitude 
and the alternating pattern Number of BEG's 
occurred more frequently in Number of patients 
lissencephaly grade 1 and 2 
patients. Most lissencephaly 
patients had a high frequency of 
epileptic attacks. A high frequency Abnormal BEG 
of epileptic attacks was not Abnormal background pattern 
Generalized fast activity > SOu V 
limited to those patients whose Generalized fast activity > 150u v 
EEG's were characterized by Generalized slow activity >300uV 
epileptiform activity. In 21 of the Asymmetrical background pattern 
114 EEG's from 10 patients with Sharp- and slow-wave complexes >800uV 
lissencephaly periods of sleep Continuous epileptic activity 
Alternating pattern** 
were recorded. During sleep, 
background-slowing as well as #Fisher Exact test, p <0,05 
sleep spindles were seen. K ** See text 
Lissencephaly Lissencephaly 
grade 1+2 grade 3+4 
48 66 
10 11 
Percentage of BEG's 
100 
92 
27 
17 
29 
8 
52* 
8 
17 
100 
97 
58* 
30 
21 
2 
26 
8 
6 
complexes did not occur. Two of ----------------------
these 21 EEG's were characterized by paroxysms of sharp activity. Continuous epileptic activity 
was found in only one of the sleep recordings. 
The results of the SEP studies are summarized in Table 3. The latencies of the SEP 
components at the point of Erb and the neck were normal according to age for all 
children.[115] The cortical components N20, P27, and N35 were absent in 7 out of the 10 
patients (an example is given in Figure 2). Only four times cortical components, probably the 
N20 peak, could be recorded. The configuration of the cortically generated complexes was 
highly abnormal; the latencies were prolonged compared to normal children. 
DISCUSSION 
Our study of 114 EEG's from 21lissencephaly type I patients is in partial agreement with the 
results of Gastaut et al.[49] We also found generalized fast activity (8-18/s.) with high 
amplitudes (pattern a) and generalized slow activity with high amplitude in the awake patient 
(pattern b). New EEG patterns in our study were: sharp- and slow-wave complexes with very 
high amplitudes (in 55% over 500uV and in 37% 800uV or more) (pattern c), the alternating 
pattern as described in the Results section (pattern d), the results of sleep analysis, and the 
changes in EEG patterns over time. Frontally localized beta activity with amplitudes up to 
200uV, is described in children with mental retardation and cerebral palsy.[50] This EEG 
32 
Chapter 4 
feature often occurred in sleep, but quite 
Table 3. Overview of the SEP after median nerve 
commonly also in the awake state. Generalized fast stimulation in 10 patients with lissencephaly 
activity with high amplitude is also seen in children type 1. 
suffering from infantile neuroaxonal dystrophy [46] ....;.;;... _____________ _ 
and, albeit with low amplitude, in progressive 
encephalopathies due to aminoacidopathies.[78] In Age at recording 
the control group of 823 patients with various 
Side of stimulation 
pathology, these patterns were rare. The two basal 
patterns (a) and (c) noticed in 20 of the 21 
lissencephaly patients, were on the contrary seen in 
only one of the 21 patients with an atypical cortical 
dysplasia. Thus, though not specific for 
lissencephaly the presence of patterns (a) and/or 
(c) suggests the diagnosis. In nine patients a more 
or less cyclical pattern between patterns (a) and 
(c) was noticed. There may be a relation between 
the high amplitude fast and slow activity found in 
our patients and the anatomic configuration of the 
lissencephalic cortex. Due to the lack of sulci, 
electric activity of a relatively large part of the 
cortex might be picked up by a scalp electrode. 
Similar to the hypothesis put forward by Ferris et 
al.[46] in children with neuroaxonal dystrophy and 
Ichikawa et al. [60], deafferentiation of the cortical 
months 
3 
16 
19 
20 
36 
. 53 
56 
84 
87 
102 
Right 
N9 N13 N20 
nd ? 24.0 
75 8.5 
? 85 
5.2 11.6 -
6.0 8.4 
nd 9.0 
6.6 10.2 -
7.2 10.2 -
6.8 10.2 -
7.4 9.2 21.6 
1 · d · nd: not done neurons resu ting in enervation supersensxtivity ? : too many artefacts 
could also be an explanation. For lissencephaly the _ : repeatedly no response 
latter possibility was mentioned before by Gastaut 
et al.[49] 
Left 
N9 N13 N20 
nd 8.8 24.0 
75 8.0 
5.2 11.8 -
5.4 8.8 
nd 9.0 
6.2 9.0 
? 10.7 19.0 
7.6 95 
7.6 9.0 
Another explanation for the generalized fast activity with high amplitudes could be an abnormal 
reaction of the lissencephalic cortex to the use of benzodiazepines. Forty-five percent of the 
EEG's from the lissencephaly patients were recorded when the patient used benzodiazepines. 
Forty-one percent of these cases showed generalized fast activity with high amplitudes. EEG's 
of patients not using benzodiazepines showed such fast activity in 48%. Thus, the use of 
benzodiazepines seems to have no influence on the occurrence of generalized fast activity in the 
lissencephalic brain. 
In addition to the EEG, evoked potentials may be useful for the diagnosis of lissencephaly. The 
absence of cortical SEP components suggests disease limited to the supratentorial grey matter. 
In this respect the absence of the "N20 component" in physiologically lissencephalic brains such 
as that of the rabbit is of interest.[17] Using the criteria of Dobyns and McCluggage [33] 
differentiation between an atypical cortical dysplasia and lissencephaly can be made by CT 
and/or MRI. In addition to radiological criteria, EEG and evoked potentials can be of 
diagnostic value also when one considers the diagnosis of lissencephaly type I. Even in the 
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EEG's recorded from the patients with an atypical cortical dysplasia the patterns described for 
lissencephaly were only sporadically present, suggesting discriminative power for the EEG to 
differentiate lissencephaly type I from other cortical disorders. 
Figure 2. Left median SSEP at age 53 months in a boy with lissencephaly 
grade 4. Normal latency of the cervical components, and absence of a cortical 
response. 
P4-Fpz 
Neck-Fpz 
O,SuV L 
5 ms 
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NEUROIMAGING IN LISSENCEPHALY TYPE I 
INTRODUCTION 
Lissencephaly is a developmental disorder of the cerebral cortex, in which sulci are not or only 
partially formed. There are two types of lissencephaly: type I, in which the disturbance mainly 
concerns the cerebral cortex, and type II, in which disturbances of the cerebellum, eyes and 
muscles are present as well. 
In 1966 it was suggested that arteriography should be performed to diagnose lissencephaly.[127] 
Before 1979 lissencephaly could only be diagnosed by autopsy.[61] In 1979 lissencephaly was 
diagnosed for the first time during life by cr scan.[ 48] In 1985 the characteristic cr features 
of lissencephaly type I were described systematically including [35]: 
* a smooth brain surface (figure 'eight' shape) or a decreased number of sulci 
* absent or few grey /white interdigitations 
* absent or incomplete opercular development 
* enlarged posterior ventricles ( colpocephaly), no hydrocephalus 
* sometimes agenesis or hypoplasia of the corpus callosum 
* sometimes small midline calcifications 
* no infratentorial abnormalities or at most slight hypoplasia of the cerebellar hemispheres. 
The aim of this study was to obtain more quantitative criteria for the diagnosis of lissencephaly 
type I by measuring a number of cerebral structures. The relationship between the number of 
sulci and cortical thickness was also examined. We also tried to fmd out whether MRI has 
advantages above cr scanning. 
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MATERIAL AND METHODS 
Data collection of patients 
Two groups of patients were studied: 
(1) 22 children with lissencephaly type I: 12 boys and 10 girls. 
(2) 44 children with a normal Cf scan and 5 children with a normal MRI: 30 boys and 19 girls. 
Figure 1A. cr scan of a 22 month old boy with 
lissencephaly 
A= 
B= 
C= 
D= 
E= 
frontal horn width 
occipital horn width 
depth of the Sylvian fissure 
width of the Sylvian ilssure 
maximum internal width of the skull between the 
Figure lB. G = minimum width of the ventricular 
system at the cella media level 
ad (1) 
Twenty-two patients with lissencephaly type I 
were collected from several child neurology 
F = :::!b:~::nal width of the skull between the departments in the Netherlands.[26] They 
were classified as lissencephaly, according to temporal bones 
the criteria of Dobyns and McCluggage.[33] 
In 6 patients MRI was performed. In 4 patients, the diagnosis was confirmed by autopsy. The 
age at which the Cf was made, varied from 1 to 218 months, with a median age of 8 months. 
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Nineteen of the 22 CT scans were performed before the age of 12 months. MR scans were 
performed between 9 and 82 months of age. 
ad (2) 
A consecutive control group consisted of patients derived from the W esteinde Hospital and the 
Juliana Children's Hospital in The Hague (Cf) and the Free University Hospital in Amsterdam 
(MRI). Their MR or CT scans were reported to be normal. The indications for the investigation 
were epilepsy, mental retardation, or trauma. Their neurological examination was normal, apart 
from developmental retardation in a number of patients. The age of these patients at the time 
of the cr scan varied from 2 to 116 months; 31% were made before the age of 12 months. MR 
scans were made from 5 to 81 months of age. 
Measurements 
cr scans of the patients with 
lissencephaly were made in the 
contributing centres. This implicated that 
different cr -scan machines were used. 
When more than one cr scan was made 
from one patient, the scan with the 
highest quality was chosen for the 
measurements. Consecutive slice 
thickness was usually 6 mm. The 
cr -scans of the patients in the control 
group were all performed in the 
W esteinde Hospital on a Siemens 
Somaton DR apparatus. Consecutive 
slice thickness was 8 mm. All MR scans 
were performed in the Free University 
Hospital, Amsterdam, on a 0,6 T con II 
apparatus. Slices of 7.5 or 10 mm 
thickness were made. Measurements 
were done on the inversion recovery 
(IR) pictures. All measurements were 
performed by one investigator to avoid 
interobserver variability. The patients 
Figure 2. MR scan of a 42 month old boy with lissencephaly. 
(SE: TR 405, TE 32, TI 0). The angle of the sylvian fissure with 
the inferior part of the temporal hom and the cerebellum is 
shown. 
were divided into two groups, younger and older than 3 years. This age limit was chosen 
because the maturation of the brain, the myelination and change of the cellular components 
takes place in the first 2 to 3 years of life.[94] 
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The following measurements on axial slices 
were made (Figure 1): 
the total number of sulci; the patients were 
classified in grades: grade 1 meaning no sulci 
or only one visible sulcus, grade 2 meaning 
two to four visible sulci, grade 3 meaning five 
or seven visible sulci, and grade 4 meaning 
eight to ten visible sulci. 
TC : Frontal and occipital Cortical 
Thickness on both sides (in mm.). 
DSF ITBW : Depth Sylvian Fissure I Total 
Brain Width at that level 
WSF IDSF : Width of the Sylvian Fissure I 
FEVI 
OEVI 
VR 
CMI 
VA 
Depth of the Sylvian Fissure 
: Frontal Evans Index = frontal 
horn width I maximum internal 
width of the skull between the 
temporal bones 
Occipital Evans Index 
occipital horn width I maximum 
internal width of the skull between 
the temporal bones. 
: Ventricular Ratio = OEVI I 
FEVI 
: Cella Media Index = maximum 
external width of the skull 
between the temporal bones I 
minimum width of the ventricular 
system at the cella media level. 
: Ventricular Angle = angle 
between the axis of the frontal 
horn and the axis of the occipital 
horn of the ventricular system. 
Table 1. The 5th, 50th and 95th percentiles of 
measurements on the cr scan in patients younger and 
older than three years with lissencephaly compared to 
the control group. 
Lissencephaly 
(N=17) 
Younger than 3 years P5 P50 P95 
FEVI* 0.15 0.29 0.43 
OEVI* 0.43 0.59 0.75 
VR 0.96 2.11 3.26 
CMI** 
Mean VA (grades) 
Mean DSF f!'BW 
Mean WSF JDSF** 
Mean LOP (mm)** 
Mean TC (mm)** 
Older than 3 years 
FEVI** 
OEVI* 
VR 
CMI* 
Mean VA (grades) 
Mean DSF (rBW* 
Mean WSF JDSF** 
Mean LOP (mm)** 
Mean TC (mm)** 
2.30 3.23 4.16 
97 113 129 
0.12 0.19 0.26 
0.29 0.88 2.80 
5.4 13.5 21.0 
8.1 12.7 17.3 
Lissencephaly 
(N = 3) 
P5 P50 P95 
0.22 0.33 0.44 
0.42 0.58 0.74 
1.62 1. 74 1.86 
2.30 2.86 3.92 
108 118 128 
0.12 0.18 0.24 
0.34 0.68 1.25 
7.5 11.2 16.1 
11.0 12.7 14.4 
Controls 
(N=24) 
P5 P50 P95 
0.19 0.25 0.31 
0.32 0.52 0.62 
1.48 2.10 2.72 
3.06 4.26 5.46 
107 115 123 
0.07 0.17 0.27 
0.09 0.16 0.25 
1.6 2.5 4.6 
2.19 3.17 4.15 
Controls 
(N = 20) 
P5 P50 P95 
0.16 0.22 0.28 
0.35 0.4 7 0.59 
1.41 1. 77 2.85 
2.88 3.88 6.44 
108 97 124 
0.10 0.16 0.12 
0.13 0.11 0.18 
1.0 2.1 3.2 
2.42 3.5 4.50 
The 5% confidence is given by the 5th and the 95 th 
percentile by 2 times + or - the standard deviation. In 
case of the WSF /DSF and the LOP the PSO is given with 
the lowest and highest value measured.*: T-test p<0.03, 
••: T-Test p <0.0001 
LOP :Length of the operculum, this is the temporofrontal separation measured on an 
axial scan through the thalamus ( in mm.). 
Additional measurements were made when sagittal images were present (Figure 2) 
ASF : Angle of the Sylvian Fissure with the inferior part of the temporal horn and the 
cerebellum. 
LSF :Length of the Sylvian Fissure (in mm.). 
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In the tables the 5th, 50th and 95th percentiles are 
given of FEVI, OEVI, VR, CMI, and of the mean 
of the measurements on both sides of VA, 
DSF/TBWindex, WSF/DSFindex, and LOP. The 
same was done with the mean Cortical thickness, 
measured on four locations, namely frontally on 
both sides and occipitally on both sides. In case of 
the WSF jDSF and the LOP only the 50th 
percentile was given, with the lowest and highest 
range.This was done, because in calculating the 
5th percentile a negative value resulted. 
RESULTS 
In Tables 1 and 2 the results of the measurements 
on the CT and MR scan in patients with 
lissencephaly compared to the control group are 
presented. In lissencephaly patients the absolute 
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Table 2. The 5th, 50th and 95th percentiles of 
measurements on the MR scan in patients with 
lissencephaly compared to the control group. In 
case of the WSF JDSF and the LOP the P50 is given 
with the lowest and highest value measured. 
Lissencephaly 
(N = 6) 
PS PSO P95 
FEVI* 0.27 0.35 0.43 
OEVI* 0.59 0.69 0.79 
VR 1.42 2.02 2.62 
CMI•• 3.804.235.84 
Mean VA (grades) 100 110 120 
Mean DSFJTBW 0.130.190.25 
Mean WSF/DSF** 0.410.781.30 
Mean LOP (mm)** 6.9 14.121.3 
Mean TC (mm)** 11.414.918.4 
MeanASF 44.7773109.9 
Mean LSF 3.7 5.7 7.7 
Normal (N 
= 5) 
PS PSO P95 
0.10 0.24 0.38 
0.300.42054 
0.80 1.96 3.12 
3.13 3.77 4.41 
111 117 123 
0.14 0.17 0.20 
0.11 0.16 0.25 
0.8 2.5 3.6 
5.6 6.7 7.8 
56 66 76 
4.4 5.9 7.4 
value of the cortical thickness was always more •: T-test p <0.03, ••: T-Test p <0.0001 
than 10 mm on CT and MR scans. This contrasts 
to the control group in which the cortical 
Table 3. Relation between 
grades of lissencephaly and the 
cortical thiclmess TC, measured 
on the cr scan. 
Grades 1 2 3 4 
thickness was always less than 5 mm on the CT scan and less than 
7 mm on the MR scan. Whereas the DSF /TBW index did not 
differ between lissencephaly patients and their controls, the 
WSF /DSF index was significantly larger in lissencephaly patients 
than in the control group. In all lissencephaly patients this index 
was higher than 0,29 and in the control group this index was 
always smaller than 0,25. The WSF /DSF index is a variant of the 
Values 10.5 105 11.6 10.4 measurements on the temporofrontal separation, which is 
10.8 10.8 11.7 11.9 described as being abnormal when this distance is 3 mm or 
more.[l14] We calculated the WSF jDSF index, to exclude the 
11.0 11.6 12.0 13.1 gnifi . ~ · I ~ th 
ma cation 1actor m our measurements. n 1act, e 
11.4 12.4 13.9 
12.1 12.5 14.9 
12.8 13.2 15.4 
16.7 
frontotemporal distance (LOP) was more than 3 mm on the CT 
scan of all lissencephaly patients. In the controls this distance was 
smaller. 
In Table 1 and 2 we can also see that the ventricular system 
(FEVI, OEVI and CMI) is significantly larger in patients with 
lissencephaly than in the normal situation. This did not concern 
Mean 11.4 11.6 12.4 12.3 the occipital horns only, since the VR was not larger in the 
SD 0.8 0.9 1.7 1.6 lissencephaly patients than in the controls. In Table 3 one can see 
that there is no clear relationship between the grade of 
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lissencephaly and the cortical thickness. The WSF /DSF 
index seems to be higher in grade 1 lissencephaly than in 
grade 2 or 3 lissencephaly, and is the smallest in grade 4 
lissencephaly (see Table 4). In lissencephaly patients, no 
focal heterotopia's were seen, the cerebellum had a normal 
aspect, or was only slightly hypoplastic. Absence of the 
corpus callosum was seen in 3 patients, the corpus callosum 
was thin in 11 patients. If present, sulci were predominantly 
seen in the frontotemporal area. No intracranial 
calcifications were present. 
Table 4. Relation between grades of 
lissencephaly and WSF/DSF index 
measured on the cr scan. 
Grades 
WSF/DSF 
DISCUSSION 
The morphologic criteria on the CT scan described by 
Dobyns and McCluggage in 1985 [33], may be 
complemented by exact measurements, which are abnormal Mean 
on the CT or MR scan in all lissencephaly patients. This SD 
study presents some values to differentiate more accurately 
the image of lissencephaly from normal. When on every CT 
1 
0.70 
0.76 
1.25 
2.30 
2.40 
2.80 
1.70 
0.83 
2 3 4 
0.60 0.45 0.29 
0.60 0.48 0.34 
0.70 050 0.41 
0.71 0.74 
0.71 0.80 
0.83 0.82 
0.83 
0.69 0.66 0.35 
0.08 0.16 0.05 
or MR scan of a severely retarded child the mean TC, and the mean WSF /DSF is measured, 
it will be virtually impossible to miss the diagnosis of lissencephaly. The WSF /DSF index is a 
measurement of the extent in which opercularisation has taken place. As expected a relation 
between the WSF /DSF index and the severity of lissencephaly was found. It was also possible 
to differentiate between lissencephaly and the control group by measuring the cortical thickness. 
We had thought that a relation could exist between the grade of lissencephaly and the cortical 
thickness, however this seemed not to be the case. In difficult cases, MR scan has advantages 
above the CT scan in visualizing the cortical surface and detecting heterotopia's. This is 
especially the case in atypical cortical dysplasia's, schizencephaly and polymicrogyria.[4,88] In 
most cases, however, the diagnosis of lissencephaly can be made on a CT scan, when all 
characteristics described above are present. The predominance of lissencephaly in the 
occipitoparietal region has already been described.[20] This is in contrast to the frontal 
pachygyria found in some patients.[116] Neither one of these predominances can be explained 
by our knowledge about gyral development.[15] 
We conclude that is possible to diagnose lissencephaly reliably on the CT scan by measuring 
the cortical thickness and the index WSF /DSF in addition to the criteria of Dobyns and 
McGluggage.[35] 
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STUDIES WITH DNA-MARKERS IN 
PATIENTS WITH LISSENCEPHALY TYPE I 
AND OTHER CORTICAL DYSPLASIAS 
INTRODUCTION 
Lissencephaly type I is a severe brain malformation resulting from a disturbed neuronal 
migration to the neocortex. Macroscopically, sulci are completely or partially absent; agyria and 
pachygyria are often present within the same brain. A classification scale was developed ranging 
from grade 1 (complete agyria) to grade 4 (complete pachygyria).[26,33] Patients with 
lissencephaly type I suffer from severe retardation and epilepsy and are often microcephalic. 
Lissencephaly type I may occur as an isolated malformation, designated as Isolated 
Lissencephaly Sequence (ILS), or as a part of the Miller-Dieker syndrome (MDS). Patients with 
MDS show more or less specific facial dysmorphisms and often have somatic abnormalities.[32] 
MDS is associated with a mini-deletion of the chromosome 17pl3.3 [31,111], because this is the 
common abnormality in MDS patients described with: unbalanced translocations (13 cases), 
pericentric inversions (2 cases), de-novo deletions (7 cases), and ringchromosomes (2 cases); 
five patients with normal karyotypes showed the deletion at 
DNA-leve1.[8,10,13,19,31,51,52,71,103,104,111,119] Ledbetter et al.[71] suggests that this deletion 
found in 15 out of 15 MDS patients is diagnostic for MDS patients. Whether any deletions 
occur in ILS has not been reported. 
We describe DNA studies in a large number of patients with lissencephaly type I and a more 
heterogeneous group of patients with cortical dysplasia. Molecular genetic analysis of the 
patients with ILS, was carried out to test the hypothesis that MDS and ILS possibly have a 
common genetic etiology.[119] 
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MATERIAL 
METHODS 
Clinical data 
AND 
Twenty-one patients with 
lissencephaly type I, collected from 
departments of Child Neurology 
and Clinical Genetic Centers in 
the Netherlands, were subject of 
this study. Details of 15 patients 
are presented elsewhere.[26] The 
diagnosis of lissencephaly was 
made in all patients on the CT 
scan using the criteria made by 
Dobyns and McCluggage.[33] The 
diagnostic criteria for MDS and 
ILS were used according to 
Dobyns et al.[32] One case of 
lissencephaly was diagnosed at 
autopsy, but did not fit in either 
the type I or the type IT 
lissencephaly. 
Figure 1. Chromosome analysis in patient 7 with MDS. A deletion 
17p13.3 is shown. 
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Figure 2. Hybridization of YNZ22.1 and YNH37 .3 in MDS families. a) absence of patemal allele YNZ22.1 in patient 
7 with MDS. b) absence of paternal allele YNH37.3 in patient 13. c) absence of paternal allele YNZ22.1 in patient 
20, d) absence of matemal allel of YNH37 .3. 
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Nine other patients with different types of cortical dysplasia, were studied, including 
schizencephaly with localised pachygyria (2 patients), atypical cortical dysplasia (5 patients), 
polymicrogyria (one patient) and a mixture of polymicrogyria and pachygyria (one patient). 
Methods 
Periferal blood lymfocytes were obtained from patients, parents and siblings for chromosome 
and DNA analysis. In some cases cultured fibroblasts were used. Chromosome preparations 
were made according to standard techniques and analyzed after trypsin Giemsa banding. For 
DNA analysis the following probes were used: YNZ22.1 (D17S5), YNH37.3 (D17S28) [82], 
144-D6 (D17S34) [66] and VAW (D17S128).[71] The order of markers is: centromere -
VA W508 - YNZ22.1 - YNH37.3 - 144D6 - telomere.[72] Total genomic DNA was isolated 
from human leucocytes or cultured cells.[77] DNA samples were digested to completion with 
restriction endonucleases, fractionated by agarose gel electrophoresis, and subjected to Southern 
blot analysis.[108] DNA fragments to be used as probes were labelled by the random primer 
method.[45] After prehybridization and hybridization the filters were washed to O.lxSSC at 
65°C. 
Table 1. Summary of the DNA analysis using three DNA probes. 
Marker F 7 M F 13 M F 20 M p F M F M 
144-D6 1.3 1.2 2.4 1.1 1.2 2.3 4.3 3.1 1.2 3.2 1.2 1.1 * 1.2 2.4 1.3 2.3 
YNZ22.1 1.2 -.4 4.3 1.3 -.4 4.2 1.4 -.2 2.3 1.3 1.4 -.3 2.3 2.4 -.2 1.3 
YNH37.3 1.2 -.3 3.3 1.1 -.2 2.2 1.1 -.2 2.1 1.1 * 1.2 -.2* 12 1.2 -.1 2.3 
VAW508 1.1-.1 * 1.1 1.2 -.1 * 1.1 1.2 -.1 * 1.1 2.1 1.1 1.2 1.2 1.1 1.2 1.2 
F /M =father/mother; P =pregnancy tested by chronionic villus sampling; numers refer to cases described by de Rijk-
van Andel et al.[26] 
* the number of alleles was determined on the basis of relative dosage of the band present on autoradiograph. 
RESULTS 
Five patients were classified as MDS, and 17 patients as ILS. All the MDS patients had a 
lissencephaly grade 1/2 (complete or nearly complete agyria). In the group of ILS patients 10 
patients had a lissencephaly grade 1/2 and 8 a grade 3/4 (a mixture of agyria with pachygyria 
or complete pachygyria). In one patient with lissencephaly classification was not possible. Nine 
other patients showed other types of cortical dysplasia. Chromosome analysis showed a deletion 
on 17p in only patient 7 with MDS (Figure 1). DNA analysis, with DNA markers for the 
17p13.3 region, showed a deletion of paternal origin in some MDS patients. Figure 2a and 2b 
show the absence of a paternal allele of YNZ22.1 and YNH37.3, respectively, in the affected 
children. In one patient the deletion was found in the maternal chromosome (Figure 2d). In the 
five MDS patients two alleles of the telomeric probe 144D6 were present. We conclude that the 
deletions are interstitial (Table 1). 
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In the family with the MDS patient no 20, DNA analysis after chorion villus sampling was 
performed in a subsequent monoamniotic twin pregnancy. Chromosome analysis showed a 
normal karyotype. Two alleles of DNA markers YNZ22.1 were detected in contrast to the single 
allele found in the DNA of the index patient (Figure 2c); two normal children were born (Table 
1). In 17 patients with ILS and one patient with non-classified lissencephaly no deletion could 
be detected with the four markers used. In all but two patients two different alleles were found 
for one of the markers YNZ22.1 or YNH37.3. In one patient dosage analysis favored the 
presence of 2 alleles. In one patient the DNA analysis was non-conclusive. Also, in the patients 
with other types of cortical dysplasia no deletions were found with the probes YNZ22.1, 
YNH37.3, 144-D6 and VAW508. 
DISCUSSION 
This study extends the expectation that all patients clinically classified as having MDS have a 
DNA deletion involving 17p13.3.[71,103,119] In 9 MDS patients (5 in the literature and 4 in 
this study) this deletion was submicroscopical and invariably included a deletion of the markers 
YNZ22.1 and YNH37.3. A deletion of the DNA markers 144-D6 and VAW508 was only seen 
in some MDS patients. In 4 MDS cases described here the deletion was seen in the paternally 
contributed chromosome. In one patient, however, the deletion was found to be of maternal 
origin. Only a single case has been observed before.[103] Apparently, the parental origin of the 
deletion in MDS is not determinant. This is in contrast to 15q11-13 deletion where the clinical 
outcome is dependent on the parental origin of the deletion: Prader-Willi Syndrome (PWS) in 
case of paternal deletion and Angelman Syndrome (AS) in case of a maternal deletion.[64] 
There, genomic imprinting does not play a role in MDS as is suggested for PWS and 
AS.[84,128] Since in the region between YNZ22.1 and 144-D6 in males a five times higher 
recombination frequency as compared to females has been observed, this might be related to 
the cause of interstitial deletions and their preference for a paternal origin.[71] 
This is the first large series of ILS patients studied by DNA analysis. Neither YNZ22.1 and 
YNH37.3, which are deleted in all MDS patients tested so far, nor VAW508 and 144D6 which 
are localised on either side of the MDS critical region were found to be deleted in DNA from 
ILS patients. Therefore it remains to be determined whether ILS and MDS have (partly) a 
common etiology. The deletion responsible for MDS is estimated to be around 300kb.[71,72] 
The probes YNZ22.1 and YNH37.3 span a region of about 20 kb. If the deletion, that might 
be responsible for ILS is very small, it may very well reside in the part not covered by these 
DNA markers. Among the other cases of cortical dysplasia (a clinically heterogeneous group) 
no deletion was found. In this group, a boy and a girl from consanguineous parents, having a 
combination of polymicrogyria and pachygyria may in fact have an autosomal recessive disorder. 
If the deletion on 17p13.3 in the MDS patient is caused by one de novo event in one germ cell, 
the risk of recurrence will be very small. However, a deletion involving 17p may also originate 
from a somatic mutation in the germ cell of the parents, as has been demonstrated in other 
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clinical entities such as the Duchenne muscular dystrophy [3] (for review see Hall).[54] This 
may lead to the recurrence in siblings, whereas constitutional DNA of the parents does not 
show the deletion. In the Duchenne muscular dystrophy the recurrence risk in mothers of 
patients with new mutations is calculated to be 14%.[3] Byers et al. hypothesed that 6% 
recurrence risk of de novo mutations of autosomal dominant osteogenesis imperfecta can be 
explained by gonadal mosaicism in one of the parents.[ll] The number of patients in the 
families studied is very small, and until now no recurrences of MDS have been described in 
families with cytogenetically normal parents. However, prenatal DNA analysis offers the 
opportunity to exclude recurrence. 
PS. Only recently, we examined a patient with clinical ILS and a deletion of chromososme 
17p13.3 (DNA markers YNZ22.1 and YNH37.3). This observation stresses the importance of 
DNA analysis in all patients with lissencephaly type I. Moreover, it may appear questionable 
whether the diagnosis of MDS may be rejected in the absence of external signs considered 
typical for this syndrome. 
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CLINICAL AND CHROMOSOME STUDIES 
IN THREE PATIENTS WITH THE 
SMITH-MAGENIS SYNDROME 
INTRODUCTION 
As was demonstrated in the previous chapter, the Miller-Dieker syndrome (MDS) is related to 
a deletion of chromosome 17p13.3.[111] Other patients with a deletion on the short arm of 
chromosome 17 were searched for to investigate the presence of a possible overlap between 
contiguous gene syndromes.[106] 
It appeared that recently a new syndrome was ascribed to a deletion of chromosome 
17pl1.2.[56] It is named "Smith-Magenis Syndrome" (SMS) as proposed by Van Tuinen et 
al.[119] after the first authors, who reported nine cases.[107] Clinical manifestations include 
dysmorphic facial features, mental retardation and hyperactivity. Twenty one patients have been 
reviewed elsewhere.[56,92,97,107,109,112,121] Most of the patients were younger than 15 years; 
the oldest, however, was 65 years old. Three additional patients, aged 1Y2, 29 and 59 years old, 
are reported here. 
CASE REPORTS 
Patient 1 
An 18 month old boy was examined because of mild psychomotor retardation. He was born at 
term as the second child of non-consanguineous parents. The older sibling was normal. 
Pregnancy and labour were unremarkable. Apgar scores were 7 and 9 after 1 and 5 minutes. 
Birth weight was 4000 grams. From early childhood he frequently suffered from otitis media and 
upper respiratory tract infections. Development was slightly retarded: smiling at the age of three 
months, rolling over from belly to back at eight months, sitting unsupported at 10 months, 
pulling himself up to a standing position at the age of 14 months, walking with support at the 
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age of 18 months. At this age he produced a few single 
words. His front teeth started to erupt at the age of 8 
months. He showed the following dysmorphic features: 
brachycephaly, frontal bossing, hypertelorism, epicanthi, 
down-slanted comers of the mouth, small low set ears 
(Figure 1) and abnormal palmar creases. Head 
circumference accorded with the P75, height and 
bodyweight with the P50. Slight convergent strabismus of 
the left eye was present as well as severe myopia of -8,5 
diopters on the right eye and -6,5 on the left. There was 
slight generalized hypotonia. Further general and 
neurological examination showed no abnormalities. He 
was able to walk with support. At the age of 20 months 
he began to walk without support. He showed 
increasingly hyperactive behaviour and at the age of three 
years there was a distinct speech retardation. Mental 
retardation was mild. After correction of the myopia his 
performance improved. Laboratory investigations did not 
show any signs of congenital infections. Thyroid function 
was normal. Metabolic screening of a 24 hour urine 
sample did not show any abnormality. A cr scan showed 
a slight atrophy of the brain, with a normal ventricular 
system. Brainstem auditory evoked potentials showed a 
mixed conductive and perceptive hearing loss of at least 
20-40dB in the 3KHz range. Conductive hearing loss 
corresponded with the presence of middle ear pathology. 
Chromosome analysis oflymphocytes and skin fibroblasts 
showed a 46,XY karyotype with an interstitial deletion of 
the proximal G-negative band of the short arm of 
chromosome 17(p11.2). Both parents showed normal 
karyotypes. Additional investigation with the probes 
pYNZ22, pYNH37.3 and p144D6, specific for the 17p 
terminal region [71], revealed no deletion in the 
17(p13.3) band. Probes in the 17(p11.2) region are not 
yet available. 
Patient 2 
This patient is the second child in a family of three 
children. The elder and younger brother were normal. 
Pregnancy and delivery were without complications. 
Figure 1. Patient 1 at the age of 36 months. 
There is brachycephaly, frontal bossing, 
hypertelorism and low set small ears. 
Psychomotor development was slow: he started to walk at the age of 3 years and even now, at 
the age of 29, he does not speak. Because of aggressive behaviour he has been treated with 
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neuroleptics. Since the age of 11, he suffered from epileptic fits, several times a year, treated 
successfully with valproic acid. The EEG showed epileptiform activity in the temporal areas. At 
the age of 29 years the height was 160 em ( < P3 percentile), and the head circumference 57 em 
(at the P50). He could utter some sounds with a deep voice. He was brachycephalic, had thick 
lips but a normal tongue with normal motility. His vision could not be determined accurately 
but he seemed to see small objects. He walked on his toes. Apart from general clumsiness, the 
neurological examinations was normal. Cytogenetic investigation showed a paracentric inversion 
in the short arm of chromosome 17 with breakpoints in 17(p11.1) and 17(p13). The karyotypes 
of both parents were normal. Blood for DNA analysis was not available. 
--------------------------Patient 3 Table 1. Symptoms of patients with the 
Smith-Magenis Syndrome. 
This 59 year old mentally retarded man is the first --------
born of twelve children. Pregnancy and delivery 
were without complications. The other children are 
healthy. Up to the age of 55, he was taken care of 
at home; his mother's death led to his 
institutionalization. In recent years there have been Broad face 
progressive walking problems. On physical Broad nasal bridge 
Flat midface 
Male: Female 
Brachycephaly 
Prominent forehead 
examination a remarkable macroglossia and thick 
lips with, however, normal motility was noticed. 
Head circumference was on the P50, his length 
was 1.64 m (smaller than the P3), and his weight 
according to length on the P90. His hands were 
short and broad with clinodactyly of the fourth and 
fifth fingers bilaterally. He could not walk 
independently for more than a few steps with a 
spastic gait of the right leg. He spoke in three or 
four word sentences. Vision was 70 percent on 
both sides. He had a hearing device on the right 
ear because of a perceptive loss of 50 dB. He 
showed hyperreflexia with an extensor plantar 
response on the right. Routine blood investigation, 
including thyroid function, electroencephalogram 
and visual evoked potentials were normal. X-ray 
Prominent jaw 
Delayed dentition 
Malpositioned ears 
Malformed ears 
Strabismus 
Myopia 
Short broad hands 
Abn. palm. creases 
Cong. heart defect 
Seizures 
Growth deficiency 
Microcephaly 
Mental retardation 
Hyperactive 
Self mutilation 
Speech delay 
Hearing loss 
Hoarse/deep voice 
1* 
11M:10F 
16/16 
13/18 
15/16 
18/21 
17/17 
11/17 
8/16 
8/17 
12/18 
7/13 
1/16 
12/14 
7/18 
9/18 
6/11 
12/18 
8/17 
20/20 
13/13 
10/13 
16/18 
10/18 
6/11 
examination of the cervical spine demonstrated 1 * 56,92,97,107,109,112,121 
osteogenic narrowing of the spinal canal. 2 = this series. 
2 
3M: OF 
3/3 
3/3 
2/3 
3/3 
3/3 
2/3 
1/1 
1/3 
1/3 
1/3 
1/3 
2/3 
3/3 
0/3 
2/3 
0/3 
0/3 
3/3 
3/3 
1/3 
3/3 
2/2 
1/3 
(%) 
14M:10F 
100 
76 
89 
88 
100 
65 
53 
45 
62 
50 
11 
82 
48 
43 
57 
57 
40 
100 
100 
69 
100 
60 
50 
Psychological tests revealed an I.Q. of 30. His Abn.palm.creases: Abnormal palmar creases 
karyotype in prophase chromosomes showed a Cong.heart defect: Congenital heart defects 
deletion of the short arm of chromosome 17, with 
break points in the regions 17p11.1 and 17p11.2. The karyotype of his father was normal. As 
his mother had died, no information about her karyotype could be obtained. This was also the 
reason that no study with DNA markers was performed. 
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DISCUSSION Table 2. Differences between MDS and SMS 
MDS SMS 
Two separate clinical conditions seem to be Male:Female 
associated with a deletion of the short arm Retardation 
17M:15F 
profound 
32/32 
31/32 
0/32 
0/32 
0/32 
6/23 
10/10 
0/32 
32/32 
14M:10F 
mild to severe 
of chromosome 17: the Smith-Magenis 
Syndrome (SMS) and the Miller-Dieker 
Syndrome (MDS).[119] The deletion in the 
MDS is located distally from the deletion 
associated with SMS. In the SMS the 
deletion is interstitial [region 17(p11.2)] 
whereas in the MDS the deletion is 
terminal or subterminal [region 
17(p13.1-2-3), always including the band 
Lissencephaly type I 
Microcephaly 
Brachycephaly 
Midface hypoplasia 
Short, broad hands 
Congenital heart defect 
Abnormal palmar creases 
Hyperactive 
Seizures 
Associated chromosome region 17(p13) 
0/8 
8/20 
19/19 
20/20 
14/17 
9/21 
10/21 
13/13 
8/14 
17(p11) 
17(p13.3)]. Until now a deletion has been according to the literature 
found in every MDS patient with probes [10,13,19,31,51,52,56,71,103,104,111,119,26] 
lying in the 17(p13.3) band [71], but 
sometimes the deletion in the MDS is too small to be detected by chromosome analysis. The 
extent of the deletion is variable in both syndromes [107,111] and this may explain the variable 
severity of the clinical pictures. At this moment no specific DNA markers in the region 17 
(p11.2) are available. In future, submicroscopical deletions in the SMS may be detected with 
proper DNA probes. This has already been demonstrated in some MDS patients.[103,119] 
(Chapter 6) Until now no recurrences within a family have been found. In one patient a 
translocation has been mentioned.[56] There have been too few cases of the SMS for an 
adequate estimate of recurrence. Germinal mosaicism for chromosomal abnormalities is known 
to occur, possibly giving rise to up to a 5% recurrence 
rate in sporadic cases of this type.[54] The clinical signs 
Table 3. Cytogenetics in the Smith Magenis of the SMS are mentioned in Table 1. Constant findings 
Syndrome* 
are mental retardation, speech delay, hyperactive 
Partial deletion 17p11.2 
Deletion 17p11.2 
Deletion 17p11.1,p12 
Deletion 17pll 
Deletion 17p11.1,pl1.2 
Inversion 17(p11.1,p13) 
Both normal parents 
Only one parent studied 
Neither parents studied 
* 107,112,56,109,97,121 
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N 
14 
5 
2 
1 
1 
1 
12 
5 
7 
behaviour, brachycephaly with a flat midface and short 
broad hands. Life expectancy is longer than initially 
believed. Mental retardation is moderately severe, with 
relatively adequate language development. The clinical 
differences between the SMS and the MDS are 
presented in Table 2. It is easy to separate these two 
conditions on clinical grounds. Microcephaly is present 
in almost every MDS patient, in the SMS in only 40%. 
The neuronal migration disturbances are very severe in 
MDS leading to complete or nearly complete agyria. In 
the SMS only one autopsy is known, showing a slight 
disturbance in neuronal organization.[107] 
Chapter 7 
Recognition of the Smith-Magenis syndrome and detailed analysis of deletions on 17p (including 
DNA analysis) may identify the minimal size of the deletion in this syndrome. Also, the relation 
between size of the deletions and symptoms [107] may become classified in this way. 
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GENERAL DISCUSSION 
The observation of two different types of lissencephaly [23] prompted the classification into type 
I and II.[32] This classification uses the data from histology, gross brain morphology, somatic 
dysmorphisms and cytogenetics (Chapter 3). This thesis concerns the type I lissencephaly only, 
involving 27 patients. Lissencephaly type I was considered as a rare congenital malformation of 
the brain [20,38] and no precise data on its prevalence at birth were known. Studying probably 
all Dutch patients in the period 1980-1988, we could establish the prevalence at birth. 
The grade of lissencephaly is related to life expectancy: patients with a less severe grade of 
lissencephaly survived longer than patients with (almost) complete agyria. The 5 year survival 
of 22 patients was 74% . The oldest patient in our studies has now reached the age of 18 years. 
(Chapter 2) 
Clinical characteristics were studied extensively in 21 patients. All patients were severely 
retarded; many had microcephaly and epileptic seizures. The main causes of death are 
infections. The 21 patients in our study were classified as cases (n=4) of the MDS, or as cases 
( n = 17) of ILS. Other larger series [ 49 ,29] found a similar relative distribution of MDS and ILS 
(Chapter 3). The diagnosis of lissencephaly type I can be made by the combination of clinical 
signs and the findings on neuroimaging (Chapter 5) or autopsy (Chapter 3). The EEG may be 
helpful in making the diagnosis (Chapter 4). The abnormally high voltages seen on the EEG 
of children with lissencephaly may be partly explained by the smooth brain surface, reducing 
the distance between the surface electrode and the electrical source. 
A genetic origin was suspected after the observation of recurrence in sibs.[30,48,76] Recurrence 
of MDS in siblings could retrospectively be explained by a balanced translocation in a parent 
(resulting in risk of unbalanced offspring).[51,52,111] Another possibility of increased risk in 
cytogenetically normal parents is a germ cell mosaicism for a ( submicroscopical) deletion of 
chromosome 17p13.3. Remarkable findings in MDS are: 
*All patients with a clinically confirmed MDS show a (submicroscopical) deletion of 17p13.3 
(with at least a deletion for DNA probes YNZ22.1 and YNH37.3). 
* In all but two cases, this deletion occurred in the paternal chromosome 
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* Future studies are needed to see if there are differences between the effects of similar 
deletions in the paternal or in the maternal chromosome 17p, as occurs in the Prader-Willi 
syndrome (paternally derived chromosome 15 deletion) and the Angelman syndrome 
(maternally derived). The two patients with a maternal deletion for the DNA probes YNZ22.1 
and YNH37.3 showed the clinical characteristics of the MDS (Chapter 6). Until now genomic 
imprinting does not seem to play a role in the MDS.[55] 
*In ILS, no deletion with DNA markers of chromosome 17p is found. It remains to be studied, 
using additional probes, if no deletions are present in ILS elsewhere. 
In the Isolated Lissencephaly Sequence an autosomal recessive genetic transmission has been 
suggested, because of parental consanguinity in one case, and the description of three affected 
brothers.[93] However there is no known recurrence of ILS among sibs in our own series. In 
our series no parents were consanguineous. The cause of the ILS is unknown, but probably 
heterogeneous. Some hypotheses about the etiology in ILS are mentioned in Chapter 1. In the 
literature some patients with a lissencephaly type I, who did not fit in either the criteria for the 
MDS nor in those of the ILS have been reported from consanguineous parents and with 
affected sibs.[1,85,98] It is obvious that one should consider an increased risk of recurrence 
until 25% in counselling parents of a child who has the ILS. 
Identifying the deletion in MDS will probably open new insights, also on normal brain 
development. Further analysis of the critical MDS region may result in isolation of the genes 
responsible for the MDS phenotype. Maybe a product made by the deleted DNA is important 
during the process of neuronal cell migration. It is also possible that the clinical criteria for the 
MDS will be revised. Until now all patients (except one, unpublished data) with a deletion of 
the DNA markers YNZ22.1 and YNH37.3 showed the MDS, and there are no MDS patients 
without such deletion (Chapter 6). The one not fulfilling the clinical MDS criteria showed a 
lissencephaly grade 3. However; the division of lissencephaly into grades of severity is artificial 
division. From embryogenesis, it follows that a continuum exists from grade 1 to 4. It was 
therefore predictable that some patients with a lissencephaly grade 3 or 4 would have the same 
etiology as the MDS. Maybe the DNA analysis will have to be included into the criteria for 
MDS. 
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SUMMARY 
Lissencephaly type I is a rare developmental disorder of the neocortex. The neuronal migration 
normally occurring especially between the 8th-16th week of gestation is severely disturbed, 
resulting in a total or partial lack of cerebral sulci. In Chapter 1 we give a review of the 
literature. With the cooperation of Dutch departments of child neurology and clinical genetic 
centres 27 patients with lissencephaly type I were collected between april1986 and august 1990. 
These data allowed for the first time to establish the prevalence at birth: 12/1000.000 births. 
Contrary to older literature indicating a short life expectancy of lissencephaly the 5 year survival 
of 22 patients in our study was 74%. However the degree of the brain malformation was 
important: in complete or nearly complete agyria 5 year survival was 54% compared to 91% 
in cases of mixed agyria/pachygyria or complete pachygyria. 
The clinical spectrum of 21 patients with lissencephaly type I (Chapter 3) shows severe 
retardation and epilepsy in all cases; 19 patients were microcephalic. Four patients fulfilled the 
criteria of the Miller-Dieker syndrome (MDS): facial dysmorphism, and other somatic 
abnormalities as syndactyly, corneal clouding, sacral dimples. The other patients were classified 
in the Isolated Lissencephaly Sequence (ILS), they showed only secondary facial dysmorphisms. 
All our MDS patients showed lissencephaly grade 1 or 2 (complete and almost complete 
lissencephaly), patients with ILS also showed lissencephaly grade 3 or 4 (mixture of agyria and 
pachygyria or complete pachygyria). Patients with lissencephaly grade 1 or 2 developed seizures 
earlier than patients with a grade 3 or 4. Patients with lissencephaly grade 1 or 2 were always 
microcephalic and showed hardly any psychomotor development. In 7 from the 11 patients with 
lissencephaly grade 3 or 4, microcephaly was present. Patients with lissencephaly grade 3 or 4 
showed some slight development. During life the diagnosis can be made by using the criteria 
described in Chapter 5 for the CT or MR scan. The CT and MR scan's of 22 lissencephaly 
patients were compared to a control group consisting of 49 patients with epilepsy, mental 
retardation or trauma and a normal CT or MR scan. The lissencephaly patients showed a 
smooth brain with a cortex thicker than 10 mm, and a foetal form of the Sylvian fissure with 
an index of the width/depth larger than 0,29. The differences with the control group were 
significant. The interdigitations of the white matter are lacking or decreased. By counting the 
number of primary and secondary sulci a division in grades 1 to 4 can be made. There was no 
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relationship between the grade of lissencephaly and the cortical thickness. If present, sulci were 
predominantly located in the frontotemporal region. In contrast to the literature no intracranial 
calcifications were seen in the MDS patients. 
EEG studies, scarcely reported in ILS and MDS, may support the diagnosis lissencephaly 
(Chapter 4). The 114 EEG's obtained from the 21 patients described in Chapter 2 were 
compared to 52 EEG's from 21 patients with an atypical cortex dysplasia and to a control group 
of 882 EEG's recorded from 823 children for various reasons. The EEG's of lissencephaly 
patients showed significantly more often the following patterns: generalized fast activity (8-18/s) 
with amplitudes above 50uV; sharp- and slow-wave complexes with amplitudes above 500 uV; 
and sometimes an alternating pattern with amplitudes up i:o 2000 uV. In lissencephaly the ftrst 
two patterns were seen in 95% of the patients compared to 5% in patients with an atypical 
cortical dysplasia and only 0,4% in the control group. SEP's by stimulating the median nerve 
were recorded for the ftrst time in ten patients. They were severely disturbed, showing normal 
latencies at the point of Erb and the neck, but absent or prolonged latencies of the cortical 
component the N20 peak with a highly abnormal configuration. 
Cytogenetic studies revealed a microscopical deletion of 17p13.3 in one of the ftve MDS 
patients. However, all ftve MDS patients had at the DNA level a deletion in the chromosome 
17 (in four patients paternally derived and in one patient maternally) when tested with the DNA 
markers YNZ22.1 and YNH37.3. In 17 ILS patients and 9 patients with an another cortical 
dysplasia similar deletions were excluded. In one family prenatal DNA analysis in chorionic villi 
excluded the recurrence of MDS in a subsequent pregnancy. All MDS patients showed a 
deletion for the DNA markers YNZ22.1 and YNH37.3. However, we recently saw a child with 
a clinical ILS and a deletion of 17p13.3 in DNA analysis, stressing the importance of DNA 
analysis in all patients with lissencephaly type I. 
To investigate the presence of a possible overlap between contiguous gene syndromes all 
patients with a deletion of chromosome 17p were collected. It appeared that a syndrome 
different from lissencephaly is related to a deletion more proximal on the short arm of 
chromosome 17. This syndrome, named the Smith Magenis syndrome, is described in Chapter 
7. 
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SAMENV ATflNG 
Lissencephalie type I is een zeldzame aanlegstoornis van de hersenmantel. Hierbij is de 
neuronale migratie gestoord, waardoor de hersengroeven niet of slechts gedeeltelijk tot 
ontwikkeling komen. Het uitwendig aspect van de hersenen is dan geheel of gedeeltelijk glad. 
Het woord lissencephalie betekent dan ook "gladde hersenen". In de klinische literatuur worden 
nog twee andere term en vaak gebruikt voor lissencephalie, namelijk agyrie en pachygyrie. Agyrie 
betekent het ontbreken van hersengroeven en bij pachygyrie zijn er enkele hersengroeven tot 
ontwikkeling gekomen. De term lissencephalie wordt vaak voor beide gebruikt. 
In hoofdstuk 1 wordt een overzicht gegeven van datgene wat er in de literatuur bekend was, 
voordat er met onderzoek begonnen werd. Migratie van neuronen naar de uiteindelijke 
hersenmantel vindt bij de mens plaats tussen de 8ste en de 16de week van de zwangerschap. 
Bij de lissencephalie type I zijn de cellen halverwege dit proces blijven steken. Meestal is er dan 
ook sprake van een gestoorde migratie van de hersenstam, zodat vaak heterotopien van de 
olijfkernen worden gezien. Het cerebellum is redelijk intact. Bij de lissencephalie type II is de 
migratie van cellen naar de hersenmantel nog ernstiger gestoord dan bij de type I. Bij de type 
IT lissencephalie zijn de horizontale cellagen dan ook in het geheel niet meer herkenbaar. 
Hoofdstuk 2 beschrijft een epidemiologische studie van patienten met lissencephalie type I in 
Nederland. Aanleiding om dit onderzoek te doen was het feit dat er geen gegevens in de 
literatuur waren te vinden betreffende prevalentie bij geboorte en de 5 jaars overleving. De 
voorgaande literatuur betrof voornamelijk beschrijvingen van enkele patienten. Dankzij de hulp 
van de afdelingen kinderneurologie en klinische genetica in de grate ziekenhuizen van ons land, 
tezamen met enkele grate instituten van de zwakzinnigenzorg, was het mogelijk om in de 
periode van april1986 tot augustus 1990 in totaal 27 patienten met een lissencephalie type I te 
onderzoeken. Er werd een prevalentie bij de geboorte berekend van 12 gevallen/1000.000 
geboorten. In de voorgaande literatuur was er van uitgegaan dat de levensverwachting bij deze 
kinderen erg kart zou zijn. De 5 jaars overleving werd bij 22 patienten bekeken en bleek 74% 
te zijn. Er werd vervolgens gekeken naar factoren die invloed hebben op de 5 jaars overleving. 
Patienten met een lissencephalie graad 1 of 2 (volledige agyrie ofbijna volledige agyria) hadden 
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een 5 jaars overleving van 54% vergeleken met 91% hij patienten met een lissencephalie graad 
3 of 4 (een mengheeld van agyrie met pachygyrie of volledige pachygyrie). 
Hoofdstuk 3 geeft de resultaten van het klinische heeld van 21 patienten met lissencephalie type 
I. Vergeleken met de vorige literatuur is onze patienten-groep een van de grootste. Aile 
patienten waren ernstig geretardeerd, hadden epilepsie en 19 patienten waren microcephaal. 
Vier patienten in deze serie voldeden aan de criteria van het Miller-Dieker syndroom: duidelijke 
dysmorfie van het gelaat met meestal andere afwijkingen in het lichaam. De andere patienten 
pasten in de criteria van de geisoleerde lissencephalie: secundaire dysmorfie van het gelaat 
zonder andere dysmorfe kenmerken. In overeenstemming met de voorgaande literatuur was dat 
de MDS patienten een lissencephalie graad 1 of 2 hadden, terwijl de geisoleerde lissencephalie 
patienten een lissencephalie heeld lieten zien varierend van een graad 1 tot 4. In de gehele serie 
hadden elf patienten lissencephalie graad 1 of 2 en de andere elf patienten een graad 3 of 4. 
Patienten met een lissencephalie graad 1 of 2 hleken eerder epilepsie te krijgen dan patienten 
met een graad 3 of 4. Patienten met een lissencephalie graad 1 of 2 waren allemaal 
microcephaal en toonden nauwelijks enige psychomotore ontwikkeling. Microcephalie was 
afwezig in vier van de elf patienten met een lissencephalie graad 3 of 4, en deze patienten 
toonden enige ontwikkeling: zij hadden enig contact met hun omgeving en konden wisselend 
kruipen. 
Tijdens het leven zal de diagnose lissencephalie hij voorkeur gesteld worden met hehulp van 
de CT of MR scan, met gehruik van hekende criteria. In de literatuur zijn de morfologische 
criteria hiervoor heschreven. In hoofdstuk 5 werden de CT en MR scan'svan 22lissencephalie 
patienten vergeleken met die van een controle groep van 49 patienten, waarhij het onderzoek 
a1s niet afwijkend was afgegeven. De indicatie voor het onderzoek hij de controle groep was als 
volgt: epilepsie, mentale retardatie en trauma. Bij de lissencephalie patienten werd er een glad 
hersenoppervlak gezien met een cortex welke dikker was dan 10 mm, en een foetale vorm van 
de fissuur van Sylvius met een index van de wijdtejdiepte van meer dan 0,29. In de controle 
groep was de cortex dikte altijd minder dan 7 mm, en was de indexwijdtejdiepte van de fissuur 
van Sylvius altijd kleiner dan 0,25. De interdigitatie van de witte stof was verminderd of afwezig. 
Door het aantal primaire en secundaire sulci te tellen kon een onderverdeling in graden worden 
aangehracht lopend van graad 1 tot graad 4. Er werd geen relatie gevonden tussen de graad van 
lissencephalie en de cortex dikte. Indien er sulci aanwezig waren, dan werden zij voornamelijk 
in de frontotemporale gehieden gezien. In de literatuur is deze locatie van enkele sulci 
heschreven, maar dan zowel frontotemporaal als occipitoparietaal. In tegenstelling tot de 
literatuur werden er geen intracraniele verkalkingen gezien hij onze patienten met het 
Miller-Dieker syndroom. 
De hijdrage van het BEG in de diagnostiek hij lissencephalie is nauwelijks onderzocht. Er 
werden 114 BEG's van 21lissencephalie patienten vergeleken met 52 BEG's van 21 patienten 
met een cortexdysplasie en met een controle groep hestaande uit 882 BEG's van 823 diverse 
andere patienten. Bij lissencephalie ziet men significant vaker de volgende patronen: 
gegeneraliseerde snelle activiteit (8-18/s) met amplituden hoven de 50 uV., piek-golfvarianten 
met een amplitude hoven de 500 uV., en een alternerend patroon met amplituden tot 2000 uV. 
De eerste twee patronen ziet men in 95% van de lissencephalie patienten, in 5% van de 
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patienten met een atypische cortex dysplasie en in 0,4% in de controle groep. SEP's werden via 
de N. medianus geregistreerd in tien lissencephalie patienten en waren ernstig afwijkend: er 
werden responsies verkregen met een normale latentietijd bij het punt van Erb en de nek, maar 
de latentie van de corticale component (N20), indien aanwezig, was sterk verlengd met een 
afwijkende vorm. In de literatuur waren niet eerder SEP's beschreven in een serie lissencephalie 
patient en. 
Chromosomaal onderzoek toonde bij een van de vijf geteste Miller-Dieker patienten een deletie 
van de korte arm van chromosoom 17. In hoofdstuk 6 zijn de resultaten beschreven van 
onderzoek met de DNA marker YNZ22.1, YNH37.3 en VA W 508 bij 5 patienten met het 
Miller-Dieker syndroom, 17 patienten met de geisoleerde lissencephalie, 1 patient met een niet 
te classificeren lissencephalie en 9 patienten met een atypische cortex dysplasie. Bij vier van de 
vijf Miller-Dieker patienten werd er een deletie gevonden voor het paternale chromosoom en 
in een Miller-Dieker patient een deletie voor het maternale chromosoom met de 
bovengenoemde markers. Bij de andere patienten werd dit niet gevonden. Er werd eenmaal 
prenatale diagnostiek verricht met DNA analyse waardoor herhaling van het Miller-Dieker 
syndroom in een volgende zwangerschap kon worden voorkomen. 
In het hoofdstuk 7 wordt het Smith-Magenis syndroom beschreven, zonder lissencephalie, maar 
met een deletie op de korte arm van het chromosoom 17p. In een paging om aile lissencephalie 
patienten te verzamelen werd er namelijk ook gezocht naar patienten met andere deleties van 
17p. De deletie in het Smith-Magenis syndroom is meer proximaal gelegen dan de deletie in 
het Miller-Dieker syndroom. De verschillen tussen beide syndromen zijn in dit hoofdstuk 
beschreven. 
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